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COMPREHENSIVE INVITED REVIEW
Bacterial Oxidases of the Cytochrome bd Family:
Redox Enzymes of Unique Structure, Function,
and Utility As Drug Targets
Vitaliy B. Borisov,1 Sergey A. Siletsky,1 Alessandro Paiardini,2 David Hoogewijs,3 Elena Forte,2
Alessandro Giuffrè,4 and Robert K. Poole5
Abstract
Significance: Cytochrome bd is a ubiquinol:oxygen oxidoreductase of many prokaryotic respiratory chains with a
unique structure and functional characteristics. Its primary role is to couple the reduction of molecular oxygen, even
at submicromolar concentrations, to water with the generation of a proton motive force used for adenosine
triphosphate production. Cytochrome bd is found in many bacterial pathogens and, surprisingly, in bacteria for-
mally denoted as anaerobes. It endows bacteria with resistance to various stressors and is a potential drug target.
Recent Advances:We summarize recent advances in the biochemistry, structure, and physiological functions of
cytochrome bd in the light of exciting new three-dimensional structures of the oxidase. The newly discovered
roles of cytochrome bd in contributing to bacterial protection against hydrogen peroxide, nitric oxide, perox-
ynitrite, and hydrogen sulfide are assessed.
Critical Issues: Fundamental questions remain regarding the precise delineation of electron flow within this
multihaem oxidase and how the extraordinarily high affinity for oxygen is accomplished, while endowing
bacteria with resistance to other small ligands.
Future Directions: It is clear that cytochrome bd is unique in its ability to confer resistance to toxic small
molecules, a property that is significant for understanding the propensity of pathogens to possess this oxidase.
Since cytochrome bd is a uniquely bacterial enzyme, future research should focus on harnessing fundamental
knowledge of its structure and function to the development of novel and effective antibacterial agents. Antioxid.
Redox Signal. 34, 1280–1318.
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I. Introduction
Cytochrome bd, first described in 1928 [(345), see alsoCook and Poole (75) and references therein], is a re-
spiratory terminal oxidase thus far uniquely identified in the
electron transport chain of prokaryotic organisms (36, 48, 151,
163, 252). As it promotes virulence in a number of pathogenic
bacteria, it is currently recognized as a prospective drug target
for the development of new antibacterial drugs.
Phylogenetically unrelated to the more extensively inves-
tigated haem/copper oxidases, such as mitochondrial cyto-
chrome aa3 (53, 58, 59, 243, 274, 301, 336), cytochrome bd
catalyzes the reduction of O2 to H2O with remarkably high
affinity, using quinols as physiological reducing substrates
(55, 163). The reaction, although not associated with a proton
pumping activity (267), is electrogenic (19, 20, 38, 51, 155,
267) and thus contributes to generating a proton motive force
(PMF) and sustaining bacterial energy conservation.
Cytochrome bd displays distinct biochemical features
with respect to haem/copper oxidases, including a d-type
O2-reactive haem and no copper atoms, which, on the con-
trary, are invariantly present in haem/copper oxidases (see
Fig. 1 for haem types). The three-dimensional structure of
cytochrome bd has remained a mystery for a long time, but it
was recently solved for two members of this protein family,
the enzymes from Geobacillus thermodenitrificans (281)
and, more recently, from Escherichia coli (280, 317), re-
vealing unexpected structural differences between the two
proteins, most likely of evolutionary significance.
A large body of evidence suggests that cytochrome bd
enables bacterial O2 consumption, either for bioenergetic
purposes, to drive specific metabolic pathways and/or to
afford protection from O2 toxicity and a variety of stress
conditions, including hypoxia, medium alkalinization, high
temperature, and exposure to toxic compounds, such as un-
couplers, antibiotics, or classical respiratory inhibitors, for
example, nitric oxide (NO), cyanide, and hydrogen sulfide
(H2S) [see Borisov et al. (46), Borisov et al. (48), Forte et al.
(115), Giuffre et al. (124), Giuffre et al. (125), Korshunov
et al. (192), Poole and Cook (252) and references therein].
Furthermore, cytochrome bd was shown to facilitate deg-
radation of harmful reactive oxygen and nitrogen species
(ROS and RNS), such as hydrogen peroxide (H2O2) or per-
oxynitrite (ONOO-) [reviewed in Forte et al. (117)], produced
by the host immune system to control microbial infections.
The growing attention that is being paid by the scientific
community toward bd-type bacterial terminal oxidases as
potential drug targets prompted us to present here a compre-
hensive update on the information currently available about
these enzymes and their impact on bacterial physiology.
A prelude on nomenclature is in order. The accepted name
for the subject of this review is ‘‘quinol oxidase (electrogenic,
proton-motive force generating), EC 7.1.1.7¢, product of the
cydAB (and other) genes.’’ It is generally called cytochrome
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bd and, less logically, ‘‘cytochrome bd oxidase.’’ The latter is
unfortunate because the complex does not oxidize cyto-
chrome bd but is cytochrome bd! However, there have been
more uncertainty and debate on the correct nomenclature of
the other major oxidase in E. coli and many other bacteria, to
which we refer, namely cytochrome bo3, bo oxidase, or bo¢.
The last name was proposed (251) because some years ago the
IUB Enzyme Nomenclature ‘‘rules’’ proposed that ligand-
binding haems should be designated with the suffix ¢. Hence
aa¢ (for cytochrome aa3) and bo¢ appeared correct.
The term cytochrome bo3, emphasising the correlation
with aa3 did not, and still does not, appear logical, because
there is, and never was, a bo1 or bo2, whereas the names a1
and a2 were both once common currency (for cytochromes
b595 and d, respectively). However, bo3 has been so widely
adopted to describe EC 7.1.1.3 ubiquinol oxidase (H+-
transporting), product of cyoABCD in E. coli (219), that we
have adopted it here.
II. Distribution, Evolution, and Regulation
of Gene Expression
A. Distribution
Cytochrome bd is a membrane-integrated complex com-
prising two to four subunits (see later, sections II.B and II.C).
The two largest and omnipresent subunits are subunits I and
II, which are encoded by the chromosomal cydA and cydB
genes. In E. coli, two different cytochrome bd-type oxidases
have been described, the best studied cytochrome bd-I
and the more recently discovered cytochrome bd-II (93).
Whereas bd-I is encoded by the cydAB operon, bd-II is en-
coded by the cyxAB operon (55). The bd-family of oxygen
reductases has a very broad taxonomic distribution with
orthologs found in various bacterial phyla. These include
diverse groups of Eubacteria, from gram-positive Firmicutes
and Actinomycetes to the whole phylum of Proteobacteria.
A number of Archaea also encode bd-family homologues,
with members of the family found in Crenarchaeota (Ther-
moproeus tenax, Pyrobaculum neutrophilum, Vulcanisaeta
moutnovskia), Euryarchaeota (Methanosarcina barkeri, Ar-
chaeoglobus sulfaticallidus) (57), and Korarchaeota (Kor-
archaeum cryptofilum) (96). Cytochrome bd-type oxygen
reductases are very common in some phyla, such as the
Proteobacteria and Actinobacteria, and sporadically distrib-
uted in others. Intriguingly, homologues of cytochrome bd
have been detected in many species described as strict an-
aerobes such as Methanosarcina barkeri, Methanosarcina
acetivorans (57), Bacteroides fragilis (13), Desulfovibrio
gigas (202), Desulfovibrio vulgaris Hildenborough (288),
Geobacter metallireducens (141), Moorella thermoacetica
(92), and Chlorobaculum tepidum (204).
A more recent survey of cytochrome bd sequences high-
lighted the diversity of molecular forms of cytochrome bd
(96). Although no clear pattern could be discerned in the
distribution of the two types of cytochrome bd among the
classes of Alpha-, Beta-, and Gammaproteobacteria, Epsi-
lonproteobacteria possess only the bd-I type. In contrast, the
majority of Deltaproteobacteria has short CydA and CydB
proteins that are evidently related to the catalytic subunits of
ancestral cytochromes bd of Bacillus subtilis (337).
In addition, a phylogenetically isolated group of Delta-
proteobacteria such as Desulfobulbus propionicus contains
cydA sequences that are longer than those of the rest of the
class, due to Q loop extensions similar to those of bd-I type
oxidases. Furthermore, the genomes of over 50 Deltapro-
teobacteria contain atypical chimeric forms of cydA that are
fused with genes encoding multiple c-type cytochromes but
not associated with a cydB gene.
The recent discovery of the small subunit CydX (68, 102,
144, 145, 314, 324) provided the opportunity for multiple
taxonomic coverage studies. Using the previously charac-
terized E. coli CydX protein as a query sequence, Allen et al.
conducted a survey for orthologs using multiple homology-
based in silico tools in completed genomes from 1095 taxa
spanning the major Eubacterial divisions (111). Their com-
prehensive approach resulted in the identification of over 300
CydX homologues that are restricted to the phylum of Pro-
teobacteria and more specifically to its Alpha, Beta, and
Gamma classes (3). Only two orthologs were identified using
refined methods in the species Leptospirillum ferrooxidans
C2–3 and Leptospirillum ferriphilum ML-04, both members
of the Nitrospiraceae family in the phylum Nitrospirae.
A more recent analysis (96) identified a class of remote or-
thologs of CydX, termed CydX-like proteins. Their function
remains currently unknown.
B. Phylogeny
Previous studies suggested that the bd-family of oxygen
reductases is an ancient innovation, already present in the
ancestor of both Bacteria and Archaea (63). However, it has
FIG. 1. Haem types in respiratory oxidases. Haem b
(haem b595 of Geobacillus thermodenitrificans cytochrome bd,
PDB entry 5DOQ); haem d (from G. thermodenitrificans cy-
tochrome bd, PDB entry 5DOQ); haem c (from mitochondrial
cytochrome c in complex with bovine cytochrome c oxidase,
PDB entry 5IY5); haem a (haem a3 of bovine cytochrome
c oxidase, PDB entry 5B1A); haem o (from Escherichia coli
cytochrome bo3, PDB entry 1FFT). PDB, Protein Data Bank.
Reprinted by permission from Forte et al. (117).
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been reported that the family may have originated in Bacteria
and was later acquired by Archaea via lateral gene transfer
(57, 135). Phylogenetic reconstructions of the bd-family
showed that lateral gene transfer plays a substantial role in the
distribution of the family, with many phyla acquiring cyto-
chrome bd genes multiple times independently. A represen-
tative phylogenetic tree is shown in Figure 2. Sequence
analysis has demonstrated that CydA and CydB have
different rates of evolution, with CydB evolving 1.2 times
faster than CydA (135). The biological relevance of this
asymmetrical evolution remains essentially unknown.
More recently, Degli Esposti et al. specifically studied
proteobacterial cytochromes bd using integrated approaches
of genomic and protein analysis (96). Their work generated
a molecular classification of diverse types of cytochrome
bd, allowing reinterpretation of their evolution and sub-
stantiating the occurrence of multiple lateral gene transfer
events. Specifically, their findings provided insights on
basal taxa of Alphaproteobacteria from which the Gam-
maproteobacterial lineage probably emerged. A duplication
of the original gene cluster of a cytochrome bd might have
occurred in the ancestors of extant Alphaproteobacteria of
the Rhodospirillales order, such as Acidocella, from which
the bd-I type of oxidase might have diffused to other pro-
teobacterial lineages.
This conclusion derives from the robust clustering of the
Gammaproteobacterium Salinisphaera hydrothermalis with
Acidocella sp. MX-AZ02 and Acidocella facilis. As Acid-
ocella lives in strongly acidic environments of wetlands and
lakes, a transfer of the cytochrome bd operon fromAcidocella
to the halophilic Salinisphaeramust have occurred in ancient
evolutionary times, when both organisms shared common
marine environments, or ancestors. The cyanide-insensitive
oxidase type, on the contrary, may have differentiated into
recognizable subtypes after another gene cluster duplication.
These subtypes are widespread in the genomes of Alpha-,
Beta-, and Gammaproteobacteria, with occasional instances
of lateral gene transfer.
The small size of CydX proteins makes it difficult to ro-
bustly resolve phylogenetic inferences and requires critical
interpretation. Similar challenges have been encountered
with relatively small globin proteins, particularly in inver-
tebrates (147) and simpler species (325). The comparative
bioinformatic approaches by Allen et al. (3) to examine the
distribution of the CydX protein across bacterial species re-
sulted in a predominant association with the Proteobacter
phylum and identified two orthologs in the Nitrospiraceae
family. Given the phylogenetic distance between these Lep-
tospirillum species and the other CydX-containing species, of
which all are contained in the Proteobacter phylum, it is
likely that these bacteria gained the cydABX operon through
horizontal gene transfer.
Furthermore, in contrast to the CydA and CydB genes, with
orthologs in a broad range of phyla, the CydX-containing
FIG. 2. Representative
phylogenetic tree of 5000
cytochrome bd sequences.
The neighbor-joining tree
was obtained with all the re-
sults of a broad DELTA-
BLAST search using cydA of
Bacillus subtilis as a query
against 5000 species of
proteobacteria excluding
most d-proteobacteria and all
e-proteobacteria, as well as
Enterobacterales. Potential
lateral gene transfers are in-
dicated. COI sequences are
defined in subtypes A, B, and
C according to the classifi-
cation proposed by Degli
Esposti et al. (96) with sub-
type A indicating their likely
ancestral nature, subtype B
for the predominance of be-
taproteobacteria, and subtype
C for the inclusion of bona
fide CIO oxidases. CIO,
cyanide-insensitive oxidase
Reprinted by permission
from Degli Esposti et al. (96).
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species were found to be members of the Alpha, Beta, and
Gamma classes of the Proteobacteria. This distribution
difference is consistent with a model in which CydA and
CydB evolved earlier than the CydX small subunit. Since the
Alpha, Beta, and Gamma classes have been suggested to be
diverged after the earlier branching of Delta- and Epsilon-
proteobacteria (70), the distribution of CydX suggests that it
may have evolved in association with the cydAB operon in a
progenitor of the Alpha-, Beta-, and Gammaproteobacteria
clades (3).
Intriguingly, the early diverging group, lacking CydX
orthologs, contains anaerobic organisms, whereas the other
includes predominantly aerobic and facultative anaerobic
organisms. Additional evidence for horizontal gene transfer
of CydX genes was found by superimposing a phylogenetic
tree based on CydX on a reference phylogenetic tree of all
investigated taxa, suggesting that Rhodospirillum photo-
metricum DSM 122 gained its cydABX operon through hori-
zontal gene transfer (3). It is very likely that the cydABX
operon has been transferred numerous times between closely
related and divergent bacterial species.
C. CydX and CydH subunits
1. CydX. Until recently, it was generally accepted that
cytochrome bd consists of two subunits. These are CydA
(*52–57 kDa) and CydB (*40–43 kDa) encoded by cydA
and cydB genes, respectively (131, 183, 222, 283). CydA
carries the quinol oxidation site and all haems, b558, b595, and
d (see section III). However, recent studies (68, 102, 144,
145, 314, 324) showed that in Proteobacteria, including
E. coli, Brucella abortus, Shewanella oneidensis, and Sal-
monella enterica serovar Typhimurium, there is a short gene,
cydX, located at the 3¢-end of the cydAB operons that encodes
a small protein essential for the function of the oxidase
(Fig. 3A).
The CydX protein appeared to be a third subunit of cyto-
chrome bd. Deletion of cydX in B. abortus leads to impaired
intracellular growth, loss of viability in stationary phase, in-
creased sensitivity to H2O2, and to the combination of the re-
spiratory chain inhibitor sodium azide and the uncoupling agent
nickel sulfate (314). Accordingly, DcydX E. coli mutants also
reveal phenotypes associated with reduced cytochrome bd-I
FIG. 3. Cytochrome bd
operons in E. coli and
conservation of CydX
throughout Eubacteria. (A)
Diagram of operons of cyto-
chrome bd-I and cytochrome
bd-II in E. coli. Note, that
gene ynhF encoding the
fourth CydH subunit of cy-
tochrome bd-I is not part
of the operon (280). (B)
Alignment of selected CydX
homologues with indication
of amino acid position. The
alignment was produced by
MUSCLE (105). (C) Align-
ment of 294 CydX homo-
logues in which amino acid
size correlates with degree of
conservation. The sequence
logo was generated by
WebLogo. Reprinted from
Hobson et al. (144) under the
terms of the Creative Com-
mons Attribution License.
Color images are available
online.
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activity (324). Phenotypes of DcydX E. coli cells show slow
growth in liquid culture, mixed-colony formation, and sensitivity
to b-mercaptoethanol. Membrane extracts from DcydX E. coli
cells have reducedN,N,N¢,N¢-tetramethyl-p-phenylenediamine
oxidase activity. Interestingly, overexpression of appX,
paralog of cydX, compensates the cydX deletion in E. coli
(324). Upon isolation of E. coli cytochrome bd-I, CydX
copurifies with CydAB (145).
The lack of CydX correlates with the absence of the high-
spin haems b595 and d, while the low-spin haem b558 is
retained (Fig. 4). The loss of the high-spin haems results in
the loss of enzymatic activity. Hoeser et al. (145) suggested
that CydX is essential for the assembly and/or the stability
of the high-spin haem site. In contrast to CydX in E. coli, its
counterpart in S. oneidensis does not seem to be essential to
the oxidase activity (68). Although markedly impaired in
function, CydX-lacking cytochrome bd from S. oneidensis
can still confer a high level of resistance to nitrite.
This suggests that a functional protein complex can be
assembled by the two large subunits only. Chen et al. (68)
concluded that complexation of CydA and CydB is inde-
pendent of CydX. Furthermore, CydX does not rely on the
CydA-CydB complex for its translocation and integration
into the membrane. Nonetheless, as in E. coli, CydX in
S. oneidensis is apparently critical to positioning and stabi-
lization of the haems, especially haem d.
CydX is conserved in over 200 species of Proteobacteria
(3, 96, 144) (Fig. 3B) (see also sections II.A and II.B). There
are cydAB operons that encode CydX-like proteins denoted
CydY and CydZ, possibly performing similar functions (3).
CydX is a 30- to 50-amino-acid protein containing a single
hydrophobic a-helix. The protein has the conserved
N-terminal region and the less conserved C-terminal region
(3, 68, 144) (Fig. 3C). The N-terminal region contains the
completely conserved W6, and the highly conserved Y3 (all
but one homologue), G9 (all but seven homologues), and
E/D25 (all but one homologue). The analysis predicts that
Y3, W6, and G9 are part of the transmembrane a-helix (3).
The N-terminal region of CydX is probably important for
function (68). Interaction of CydX with the cytochrome
complex may be coordinated through a combination of
interactions between multiple residues rather than being
dependent on individual residues (144).
A third subunit, denoted CydS, was identified in the
structure of cytochrome bd from G. thermodenitrificans
K1041 and is thought to stabilize haem b558 (281) (see section
III). CydS is conserved in Bacillales but shows no sequence
similarity to its proteobacterial counterparts. Surprisingly,
although the solved structure of the E. coli cytochrome bd-I
shows the similar location of CydX (280), the CydX-lacking
bd-I protein still retains haem b558 (145) (Fig. 4).
In summary, it seems likely that all cytochromes bd pos-
sess a third, small subunit. The CydX or CydX-like compo-
nent could be overlooked in cytochrome bd of somemicrobes
using standard biochemical and genomic methods. It is in-
deed difficult to identify such a small-size protein in cyto-
chrome bd complex preparations, as well as the
corresponding short gene out of many short open reading
frames. One more possible reason for the apparent absence of
cydX in some cydAB operons is that the gene could have
migrated to another part of the genome. For instance, 4 of 20
CydS in Bacillales are encoded at gene loci far apart from
their cydAB operons (281).
2. CydH. The structure of the E. coli cytochrome bd-I
reveals a fourth, previously unknown subunit called CydH
(280) [or CydY (317)]. Like CydX, CydH is a small non-
catalytic accessory single transmembrane subunit (see sec-
tion III). The subunit is encoded by the orphan gene ynhF,
which is not part of the cydAB operon. Only members of the
proteobacterial clade with cytochromes bd belonging to
subfamily L (one of the two subfamilies of the bd enzymes,
see section III) seem to have CydH homologues (280). The
role of CydH appears to be more than just ‘‘structural.’’ The
subunit blocks the O2 entry route to haem b595 in the E. coli
cytochrome bd-I (317). In the G. thermodenitrificans en-
zyme, CydH is absent, and therefore, this channel is open and
provides O2 access to haem d located in place of haem b595 at
this site (281) (see also section III).
D. Regulation of expression
Regulatory mechanisms underpinning the expression of
cytochrome bd have long been the subject of intense study,
driven by the extraordinary features of this oxidase and its
physiological significance. For example, the earliest studies
on bacterial respiration revealed that cytochrome bd, recog-
nizable initially by its distinctive optical properties, was
maximally expressed in E. coli under conditions of low ox-
ygen supply (252, 272). This is now considered to be a re-
flection of the very high oxygen affinity of this oxidase (88).
Expression is also increased in the presence of cyanide (8),
FIG. 4. Different absorption spectra (dithionite-
reduced minus air-oxidized) of purified E. coli cyto-
chrome bd-I containing (red) or lacking (black) CydX.
The absorbance difference between 400 and 500 nm is
scaled down to one-fifth of intensity. The black spectrum
shows the peaks at 429.5, 531, and 562 nm corresponding to
haem b558. The signals from haem b558 are also present in
the red spectrum. In addition, the red spectrum displays a
shoulder at about 440 nm and a peak at 594 nm corre-
sponding to haem b595, and a peak at 629 nm corresponding
to haem d. The Soret signal from haem d in the red spectrum
is superimposed with that of haem b558 at 430 nm. The 655-
nm signal (*) is an artifact of the spectrometer. Reprinted by
permission from Hoeser et al. (145). Color images are
available online.
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NO (217), carbon monoxide (CO) (332), and Ru- and Mn-
containing CO-releasing molecules (CORMs) (94, 333).
By far, the best-studied systems are in E. coli, where
regulation has proven to be extremely complex, intricate,
and responsive. Although we focus on the mechanisms in
E. coli, which involve multiple promoters and at least three
classes of transcriptional regulators, the identity of the
regulators and their modes of action differ among genera,
but are outside the scope of the present review. For exam-
ple, in Shewanella, the two cytochrome bd subunit genes
are cotranscribed with a third gene, cydE, that encodes a
GbsR regulator that represses cydAB expression (340).
In several gram-positive genera, the transcription factor
Rex is implicated in the regulation of genes important for
fermentation and growth at low oxygen tensions, sensing the
cellular redox poise in the form of NADH/NAD+ ratios.
Examples of the role of Rex in regulating cytochrome bd
expression are found in Streptomyces (56, 207), Sacchar-
opolyspora spinosa (348), and Bacillus subtilis (200, 266,
291, 331).
In Rickettsia conorii, a small regulatory RNA is implicated
as a potential regulator of cydA (234). OxyR is a master reg-
ulator in a wide range of bacteria, but its role in regulating
cytochrome bd appears limited: an OxyR binding site has been
identified in the promoter region of cydA in Corynebacterium
glutamicum (225, 316) and it plays a role in regulating electron
flux to cytochrome bd in S. oneidensis (330).
Here we focus on the complex systems involved in regu-
lating cytochrome bd-I of E. coli. Control of cytochrome bd
expression in E. coli is achieved primarily through the
combined and complex actions of ‘‘fumarate nitrate reduc-
tion’’ regulator (FNR) and the ArcB/ArcA two-component
system. A regulatory complex of five promoters initiates the
transcription of cydAB: four of them (P1–P4) are coordinately
regulated by oxygen (via ArcA and FNR). ArcA binds at
three sites at this promoter (214), but only one is essential for
transcriptional activation (82). Also, two distinct sites for
binding FNR are discernable (82): the downstream FNR-2
site is critical for FNR-mediated repression in vivo, whereas
the upstream site (FNR-1) plays an ancillary role in regula-
tion of the cydAB operon by oxygen (129). Detailed discus-
sion of the biochemistry of these oxygen-sensing global
regulators is beyond the scope of this review but a summary
follows.
FNR is a protein of the CPR-FNR superfamily of tran-
scription factors, which all possess an N-terminal sensory
domain and a C-terminal DNA-binding domain (132). FNR
regulates transcription of target genes (its regulon) under
anaerobic conditions by assembly of an oxygen-labile
[4Fe-4S] cluster into the N-terminus. Assembly of this cluster
facilitates formation of an FNR dimer with enhanced DNA-
binding activity. It targets specific nucleotide sequences in
selected promoters, where it acts as an activator of ‘‘anaer-
obic genes’’ and a repressor of ‘‘aerobic genes.’’ As oxygen
availability increases, the [4Fe-4S] cluster is degraded to a
[2Fe-2S] cluster so that site-specific inhibition is inhibited.
The details of how O2 interacts with FNR are described
elsewhere (83) and the effects of NO on the cluster are given
in Crack et al. (84) and Cruz-Ramos et al. (87).
In Azotobacter vinelandii, CydR is an FNR-like protein,
encoded adjacent to cydAB (180), that represses cydAB ex-
pression (339). Interestingly, FNR is structurally and func-
tionally related to the cAMP receptor protein (CRP) [for a
review see Green et al. (132)]. InMycobacterium smegmatis,
CRP directly regulates the expression of cydAB in response to
hypoxia (9). No CRP site is present in the M. smegmatis
cydDC promoter.
While FNR is a direct sensor of oxygen (and NO), ArcBA
is a representative of the two-component regulators and is an
indirect oxygen sensor. The ArcB protein is a membrane-
integral sensor kinase and ArcA is its cognate response reg-
ulator. Two key cysteine residues in the cytosolic domain of
ArcB must be reduced for the protein to be functional. It is
generally accepted that it is the redox poise of respiratory
chain quinones, such as those transferring electrons to the
oxidase itself that is key to Arc function. Both the ubiquinone
and menaquinone (MQ) pools are thought to be involved in
regulating ArcBA (15). Fermentation products act as allo-
steric effectors (121, 122).
When oxygen is available, ArcB transits from being an
autokinase to a phosphatase, via formation of two intermo-
lecular disulfide bonds, resulting in the formation of a co-
valently linked ArcB dimer. Ultimately [for references see
Bettenbrock et al. (30)], a phosphate group is transferred to
ArcA, which assumes the role of a sequence-specific DNA-
binding protein. In this form, it controls expression of several
target promoters including cydAB (284). The system is
switched off by the phosphatase activity of the oxidized
(disulfide) form of ArcB, via dephosphorylation of ArcA
(120).
When the oxygen tension drops, ArcA is phosphorylated
by ArcB and activates cydAB transcription (81, 153). In early
experiments, cytochrome bd expression was shown to reach a
maximum at <2% oxygen tension (320) but more deliberate
control of oxygen availability (2) questions this. When oxy-
gen is decreased further, FNR becomes active and represses
cydAB transcription (82, 320). A unique feature of the cydAB
operon is the fact that FNR repression requires the presence
of a functional ArcA protein (81, 82, 130). FNR has been
proposed to act as an antiactivator by counteracting ArcA-
mediated activation rather than directly repressing tran-
scription (82, 130).
A role for the histone-like protein H-NS has also been
reported (130). H-NS binds to an extended region within the
cydAB promoter element, including sequences upstream
from, and overlapping, the four regulated promoters. Oxygen
control of cydAB transcription is thought to be mediated by
three alternative protein-DNA complexes that are assembled
sequentially on the promoter region as the cells are shifted
from aerobic to microaerobic and to anaerobic conditions.
A recent systems approach to the oxygen response of
cytochrome bd-I and the two other oxidases of E. coli
(30, 104) has adopted a rigorous chemostat methodology,
transcriptome profiling, and powerful mathematical model-
ing tools (287). In chemostats poised at quantified and con-
stant oxygen provision rates, 89 genes exhibited expression
changes when oxygen availability was modulated experi-
mentally (276). O2 availability in the chemostats was ex-
pressed as ‘‘% aerobiosis’’ (2), defined by the converse
relationship between declining qacetate (a measure of ‘‘over-
flow’’ metabolism) and increasing oxygen transfer rate.
Steady-state simulation results of the three oxidase activities
in comparison with measurement data showed good corre-
lations with measured oxidase levels (104).
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Cytochrome bd-I levels were very low at the highest and
lowest rates of O2 transport and highest at 56% aerobiosis.
Expression of this operon was 6.4-fold enhanced compared
with anoxia (where acetate flux is maximal).
The expression of the second cytochrome bd-type oxidase
of E. coli, cytochrome bd-II, is subject to less extreme reg-
ulation and has been studied less intensively; the function of
this oxidase is unclear. Our current knowledge of the struc-
tures of cytochromes bd-I and bd-II suggests that their
functions should be similar and perhaps interchangeable, yet
they appear to be differentially regulated. Whereas cydAB is
maximally expressed at O2 tensions between microaerobic
and oxygen-rich conditions (320), appCB, encoding cyto-
chrome bd-II, is maximally expressed at 0% aerobiosis (using
the acetate criterion). Spectroscopic assays of oxidase levels
confirm these conclusions (276, 319). In contrast, the cy-
oABCDE operon, encoding cytochrome bo3, was maximally
induced under fully aerobic conditions.
Thus, shifts in oxidase expression are consistent with a
progressive switch from fermentation to microaerobic res-
piration (where cytochrome bd-I acts as the dominant oxi-
dase) and then to aerobic respiration (where cytochrome bo3
is the prevailing terminal oxidase. Posttranscriptional regu-
lation appears not to play a major role in oxidase expression.
III. Structure and Assembly
A. Structure
To date, cytochrome bd structures from two bacteria have
been reported. In 2016, the first crystal structure of cyto-
chrome bd, from the thermophile G. thermodenitrificans
K1041, was determined at 3.1 Å (Protein Data Bank [PDB]:
5DOQ) and 3.80 Å (PDB: 5IR6) resolutions (281). The struc-
ture shows that this is a three-subunit enzyme. Both main
subunits, CydA (*52kDa) and CydB (*40 kDa) (283), are
integral membrane proteins, each consisting of nine trans-
membrane helices, with the N-terminus and the C-terminus in
the periplasmic and cytoplasmic sites, respectively (Fig. 5A).
CydA and CydB are encoded by paralogous genes, which re-
sulted from a duplication of a single ancestral unit codifying for
a homodimeric oxidase (75). The heterodimeric structure is
stabilized by hydrophobic interactions involving residues
coming from the paired a3, a4, and a9 of CydA and CydB. The
CydA and CydB subunits are structurally similar (root mean
FIG. 5. (A) Ribbon model of the
bd oxidase from G. thermo-
denitrificans. The subunits CydA
(green), CydB (cyan), and CydS
(brown) are shown. The haem
groups b558, b595, and d are re-
presented by stick models ( pink).
Helices a3, a4, a5, a6, and a9 re-
ported in the main text are labeled.
(B) Ribbon model of the bd-I oxi-
dase from E. coli. The subunits
CydA (green), CydB (cyan), CydX
(yellow), and CydH (magenta) are
shown. The haem groups b558, b595,
and d are represented by stick
models ( pink). UQ8, ubiquinone-8.
Color images are available online.
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square deviation [RMSD]: 3.1 Å). A search for structurally
similar subunits in PDB yielded a relatively low similarity
with Complex III (cytochrome bc1) from Flavobacterium
johnsoniae (PDB:6BTM; RMSD: 3.4 Å; Fig. 6A) (311) and
Rhodothermus marinus (PDB:6F0K; RMSD: 3.4 Å;
Fig. 6B) (307), and polysulfide reductase from Thermus
thermophilus (PDB:2VPX; RMSD: 3.2 Å; Fig. 6C) (162).
CydS, in turn, is a single transmembrane helix of 33 amino
acid residues (*4 kDa), which is positioned at the periph-
eral interface formed by helices a5 and a6 of CydA. CydS is
proposed to stabilize haem b558 during potential structural
rearrangements of the CydA upon binding and oxidation of
quinol (281).
In 2019, using single-particle cryoelectron microscopy
(cryo-EM), two structures of the E. coli cytochrome bd-I, in
lipid nanodiscs with a bound Fab fragment (280) and in the
presence of aurachin C (317), were determined at 2.68 Å
(PDB: 6RKO) and 3.3 Å (PDB: 6RX4) resolutions, respec-
tively. The results of the two articles (280, 317) are consis-
tent. It turns out that cytochrome bd-I is a four-subunit
enzyme (Fig. 5B). The arrangement and architectures of
subunits CydA, CydB, and CydX are similar to the overall
structure of the cytochrome bd from G. thermodenitrificans
K1041 (Fig. 7). A fourth, previously unknown, subunit, ab-
sent in the G. thermodenitrificans oxidase, was named CydH
(280) [or CydY (317)]. CydH appears to be a single trans-
membrane subunit that binds in the cleft between trans-
membrane helices a1 and a9 of CydA.
Cytochrome bd displays a unique binding domain for the
oxidation of quinol called the Q-loop (218, 226). This is
the loop connecting the a6 and a7 helices of CydA, facing
the outside of the prokaryotic cell (Fig. 8A). The Q-loop is
of variable length within the family (239, 282). Based on its
size, the bd-type oxidases are divided into two subfamilies:
L (long Q-loop) and S (short Q-loop) (7, 48). Cytochromes
bd from G. thermodenitrificans and E. coli belong to S and
L subfamilies, respectively. The quinone-analogue aur-
achin D is a powerful and relatively selective inhibitor of
the E. coli cytochrome bd-I (221). Duroquinol:O2 oxido-
reductase activity of the isolated bd-I oxidase is inhibited
by aurachin D with IC50 of 35 nM (317). In accord with
these data, aurachin D inhibits O2 consumption of cyto-
chrome bd in inverted membrane vesicles of M. smegmatis
with an IC50 of *400 nM (212).
An in silico docking model of the complex between aur-
achin D and cytochrome bd (Paiardini, unpublished data)
suggests that indeed aurachin D binds at the cytochrome bd
quinol oxidation site (Fig. 8B), in close proximity to the
Q-loop. The docking data (Fig. 8B; Paiardini, unpublished
data) are consistent with the fact that, in the structure reported
by Theßeling et al. (317), there is a small but significantly
FIG. 6. Structurally similar subunits of G. thermodenitrificans bd oxidase. Structural superposition of G. thermo-
denitrificans bd oxidase (green) with (A) Complex III (Cytochrome bc1) from Flavobacterium johnsoniae (blue; PDB:6BTM;
RMSD: 3.4 Å); (B) Complex III (Cytochrome bc1) from Rhodothermus marinus (orange; PDB:6F0K; RMSD: 3.4 Å; and (C)
polysulfide reductase from Thermus thermophilus (gray; PDB:2VPX; RMSD: 3.2 Å). Superposition was carried out using
PyMOL (Version 2.0; Schrödinger, LLC). RMSD, root mean square deviation. Color images are available online.
FIG. 7. Superposition of G. thermodenitrificans bd
oxidase (PDB:5DOQ; silver) and E. coli bd-I oxidase
(PDB:6RKO; gold). The positions of haems b558, b595, d,
and UQ8 in 6RKO are shown as reference. The mea-
sured RMSD is 4.7 Å. Superposition was carried out using
PyMOL (Version 2.0; Schrödinger, LLC). Color images are
available online.
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unexplained electron density in a pocket comprising E257 and
K252, possibly due to a bound aurachin C. The role of the
Q-loop in the as-isolated cytochrome bd from E. coli without
substrate, in the presence of ubiquinone-1 (substrate analogue),
and a quinolone-type inhibitorAD3–11was investigated (280).
The Q loop is divided into two domains: a flexible, disordered
QN (N-terminal part) and a rigid, well-ordered QC (C-terminal
part). The QC domain that defines the L-subfamily does not
appear to be involved in substrate binding.
A feature that emerged from the crystal structure of the cy-
tochrome bd from G. thermodenitrificans was the unexpected
triangular arrangement of the three haems located on CydA.
This suggests a direct electron transfer from haem b558 to haem
d, followed by equilibrationwith haem b595 (Fig. 9A and section
V). The evolutionarily conserved W374 could participate in
the electron transfer between haem b558 and haem d (281).
The E. coli cytochrome bd-I preserves triangular organi-
zation of the haems (Fig. 9B). The location and coordination
of haem b558 are equivalent in both enzymes. It is coordinated
by H186 andM325 (M393 in E. coli). Surprisingly, however,
haem b595 and haem d in theE. coli structure are interchanged
with respect to the G. thermodenitrificans enzyme (Figs. 5
and 9). In the latter structure, haem b595 is hexacoordinate
having H21 and E101 (H19 and E99 in E. coli) as axial
ligands. It is buried in the protein interior deeper than haem d.
Haem d has E378 (E445 in E. coli) as the axial ligand. In the
E. coli structure, conversely, haem b595 is pentacoordinate
with E445 as the axial ligand. Furthermore, haem b595, rather
than haem d, is located near the periplasmic surface.
There is a discrepancy in the nature of the axial ligand to
haem d between the two E. coli bd-I structures. Safarian et al.
(280) claim that this is H19, whereas Theßeling et al. (317)
report that the ligand is E99. The difference in the haem d axial
ligand observed in the two static structures may indicate flex-
ibility in the haem iron/ligand coordination bond, assuming that
the haem d iron may coordinate no more than one protein axial
ligand at a time. In line with this suggestion, lability (transient
formation/breaking) of the haem d iron bond to a protein
ligand in one of the states of the catalytic cycle (the one-
electron reduced ‘‘mixed-valence’’ state) was noted earlier in
time-resolved experiments (304). This implies the possible
functional significance of the intraprotein axial ligand ex-
change in the haem d coordination sphere during catalysis.
The short edge-to-edge distance (6.7 Å) between haem
b558 and haem b595 and the interchanged positions of the
high-spin haems suggest a sequential interhaem electron
FIG. 8. Cytochrome bd displays a unique binding domain for the oxidation of quinol. (A) Ribbon model of G.
thermodenitrificans bd oxidase with aurachin D bound (slate sticks). (B) Detailed representation of the interaction between
aurachin D and G. thermodenitrificans bd oxidase. The residues at less than 4 Å from aurachin D are represented as sticks,
and labeled according to the crystal structure of bd oxidase from G. thermodenitrificans (PDB 5DOQ). Haem b558 is
represented as purple sticks. The key polar interactions of aurachin D with residues E257 and D239 are represented as
yellow dashed lines, and the distance between the involved atoms is reported (Å). The approximate position of the density of
aurachin C as found in bd oxidase from E. coli (PDB: 6RX4) is reported as mesh. Docking was done using MVD (CLC
Bioª) starting from the energy minimized structure of aurachin D and PDB file 5DOQ and considering search space a
sphere of 12 Å centered on the Fe atom of haem b558. The best docked pose, as assessed by the energy of interaction score
(-128.2), is shown. MVD, Molegro Virtual Docker. Color images are available online.
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transfer in the E. coli oxidase, b558 / b595 / d, as proposed
earlier (48, 258) (Fig. 9B and section V). The totally con-
served W441 possibly mediates electron transfer between
b558 and b595. It is worth noting that the plane of haem b558 is
organized more-or-less at right angles to the membrane plane
in both the E. coli and G. thermodenitrificans oxidases,
whereas either d or b595 is oriented at about 45
o to the
membrane plane in the two oxidases; these two high-spin
haems are interchanged in the two species (280, 281, 317).
Such an arrangement was predicted by electron paramagnetic
resonance analyses of membrane multilayers rotated within the
instrument cavity in 1980 before any structural data were
available (250).
CydB contains a tightly bound ubiquinone-8 (UQ8;
Fig. 5B). The molecule is located at a hydrophobic pocket,
about 3.5 nm from haem d, in a near-symmetric conformation
relative to haems b558 and b595. The significant distance from
the haems makes its direct participation in electron transfer
to/from the haems or oxygen reduction unlikely. The bound
UQ8 possibly plays a structural role (280, 317).
Cytochrome bd is not active as a transmembrane pump, but
a net proton flux results from quinol oxidation and conse-
quent proton ejection at the periplasmic side of the mem-
brane and uptake of cytoplasmic protons during oxygen
reduction. Two alternative proton pathways in the G. ther-
modenitrificans structure have been indicated, one in CydA
and the other in CydB, which converge on haem b595 (Fig. 10)
(281). In the E. coli enzyme, there is a hydrophilic, water-
filled H-channel that connects the cytoplasm to haem d by the
CydA pathway (Fig. 11). A chain of water molecules runs
until D58 of CydB, and then, the conserved S108, E107, and
S140 of CydA continue the pathway to haem d. Near D58, the
H-channel branches and runs along the WDGNQ motif of
CydB forming the CydB pathway branch (not shown). Sur-
prisingly, in the center of CydB at W63, the hydrophilic
branch merges with the hydrophobic oxygen-conducting
channel (O2 channel, Fig. 11).
The O2 channel that goes parallel to the membrane plane
connects the lipid interface to haem d (280, 317). In the G.
thermodenitrificans structure, due to the lack of voluminous
pathways there, O2 may gain access to haem d via a potential
O2 entry site located laterally at a short distance from haem d.
FIG. 9. Representation of the triangular arrangement
of the three haems, in stick models, bound to CydA in (A)
G. thermodenitrificans bd oxidase and (B) E. coli bd-I
oxidase. Haems b558 and b595 are depicted in violet and haem
d in cyan. The distance between Fe atoms is represented as
dashed gray lines and labeled. In G. thermodenitrificans bd
oxidase, this arrangement suggests a direct electron transfer
from haem b558 to haem d, followed by equilibration with
haem b595. The evolutionarily conserved W374 (W441 in
E. coli bd-I oxidase) could mediate electron transfer between
haem b558 and haem d. Surprisingly, haem b595 and haem d
in the E. coli bd-I oxidase structure are interchanged with
respect to the G. thermodenitrificans enzyme. Adapted from
Safarian et al. (280, 281). Color images are available online.
FIG. 10. Potential proton transfer pathways in the bd
oxidase from G. thermodenitrificans (PDB 5DOQ). The
side chains of the residues that are involved in CydA and
Cyd B proton transfer pathway are shown. Proton transfer
pathways are crucial for protons to gain access to the
oxygen-binding site. Two potential proton transfer routes,
named the CydA pathway and CydB pathway respectively,
have been identified: the former is located inside of the four-
helix bundle a1–4 of CydA and the latter in the symmetry-
related a1–4 four-helix bundle of CydB. HDD, haem d;
HEB, haem b595. Adapted from Safarian et al. (281). Color
images are available online.
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Thus, for the G. thermodenitrificans cytochrome bd, O2
present within the membrane could bind to haem dwithout the
need for any functionally conserved protein cavity (281). The
E. coli CydH occupies the O2 entry site in the G. thermo-
denitrificans enzyme, where CydH is absent, thereby pre-
venting access of O2 to haem b595 from the hydrophobic lipid
bilayer (280, 317).
B. Assembly—the role of CydDC
Understandably, when molecular genetic tools were
brought to bear on cytochrome bd, the structural genes (i.e.,
encoding the oxidase subunits) were the earliest focus. Mu-
tants lacking the oxidase could be isolated and the encoding
genes were cloned, sequenced, and analyzed, thus laying the
foundations for studies on oxidase organization and function.
However, other genes, involved in assembly of the oxidase
complex in E. coli, were quickly found and these too have
generated new information and hypotheses.
In E. coli, the cydDC genes are distant from the structural
genes on the chromosomal map (123), but in certain bacteria
they occur in a single operon with cydAB thus being ex-
pressed on one continuous transcript, as occurs in Bacillus
subtilis (337). Other bacteria have oxidases that resemble
cytochrome bd-I, yet have no spectrally detectable high-spin
haems (b595 and the d-type haem) as inCampylobacter jejuni;
nevertheless, two genes (cj0081, cj0082) that encode proteins
similar to the CydAB proteins in E. coli were identified from
genome sequences (241). These issues are discussed in Poole
et al. (253).
Neither cydD nor cydC is an essential gene in E. coli, as
evidenced by the strategies that identified cydC and cydD
mutants. However, Eng et al. (108) describe E. coli cydC as
an essential gene and suggest that cytochrome bd-I (i.e.,
CydABX) and CydDC do not always co-occur: among the
1965 genomes analyzed, 407 species exhibited highly con-
served cydC genes, but only 53 showed a cydB homologue. It
is puzzling that cydDC genes appear to be found in so many
genomes that do not encode cytochrome bd-I; Kranz et al., in
the 33 bacterial genomes analyzed, found none (197), al-
though six species encode the oxidase but not CydDC,
namely Rickettsia prowazekii, Chlamydia tracomatis, C. je-
juni, Porphyromonas ginigivalis, Aquifex aeolicus, and
Thermotoga maritima. All were claimed to lack both CydDC
and cytochrome bd-I by Eng et al. (108).
Furthermore, neither Geobacillus nor Mycobacterium
species were found by Eng et al. to encode cytochrome bd-I,
despite the fact that other authors report functional or struc-
tural studies on cytochrome bd-I from these bacteria (23, 114,
281). Caution is urged when deducing the apparent absence
of genes from a genome, particularly genes such as cydDC
that are members of a very large and diverse family—the
adenosine triphosphate (ATP)-binding cassette (ABC)-type
transporters.
1. The cydDC genes. In addition to the structural genes
that encode the cytochrome bd complex, detailed above, it is
now clear that, in many bacteria, two additional genes
function in proper assembly of the oxidase. In E. coli, where
information is most comprehensive, and most bacteria, they
are named cydC and cydD. These genes encode a transport
system in the ABC class and are widely thought to be the sole
two components of a membrane-integrated export system.
By the early 1990s, cydA and cydB encoding the cyto-
chrome bd-type terminal oxidase (bd-I) (61) were mapped to
an operon at 16.6min (188) on the chromosomal map. Remote
from the cydAB locus and located at 19.2min (123), a further
gene, implicated in ‘‘cytochrome d assembly,’’ was also
identified. Mutants in this gene (named cydC) were devoid of
absorbance bands in the visible spectrum that could be at-
tributed to cytochrome bd-I; however, the spectrum was re-
turned to wild-type (WT) characteristics by introducing the
cloned cydC+ gene on an episome.
Transcription/translation experiments and Western immu-
noblotting of membranes from a cydC strain showed that the
CydA and CydB subunits were present but diminished in
membranes from a cydC strain relative to the isogenic cydC+
strain (123). Expression of the oxidase subunits in a cydC strain
demonstrated that the b595 and b558 haems were overproduced,
but the haem d component was absent. Thus, a plausible hy-
pothesis was that CydC is involved in biosynthesis of haem d;
in the absence of this haem, the oxidase subunits are largely
absent and destabilized (123). Note that Siegele et al. inde-
pendently described the cydC gene but named it surB, because
its gene product was required for E. coli cells to exit (i.e.,
survive) in a stationary phase aerobically (299).
In 1989, we identified a fourth cyd locus by adopting a
markedly different strategy (260): survivors of a classical
nitrosoguanidine mutagenesis were screened using a hand
spectroscope (on samples held at 77 K) for loss of the
characteristic absorbance at 630 nm of reduced cytochrome
bd. The mutant gene in one such isolate was mapped to
19.3min (260). Furthermore, a gene implicated in the ability
to survive at elevated temperatures, htrD, was shown, after
correcting a missing G in the earlier sequence, to be identical
to cydD (98).
FIG. 11. Oxygen and proton channels in E. coli cyto-
chrome bd-I (PDB: 6RKO). Adapted from Safarian et al.
(280). The proton channel (cyan spheres) connects haem d
directly to the cytoplasm via the CydA pathway. The oxy-
gen channel (O2 channel, green spheres) connects the UQ8
interface with heme d. Color images are available online.
BACTERIAL OXIDASES OF THE CYTOCHROME BD FAMILY 1291
Cloning of the cydC and cydD genes (255) resulted in a
fragment of chromosome originating in the 19-min region of
the Kohara map, and thus consistent with earlier P1 mapping
data (260). When such plasmids were used as templates for
in vivo protein synthesis, two proteins identified as CydD
(61 kDa), calculated to be 63 kDa, and CydC (59 vs. 63 kDa)
(255) were generated. CydD and CydC were similar: the
deduced amino acid sequences revealed 50% similarity and
27% identity. Hydropathy profiles predicted that the CydDC
complex comprises two similar membrane proteins, and it
was identified as the first documented example of a bacterial
heterodimeric ABC transporter, probably an exporter, by
comparison with known ABC family members.
2. The CydDC proteins: structure and function. Based
on analysis of hydrophobicity of CydD and CydC, it was
predicted that both subunits would have six transmembrane
helices, the C-terminal portion of each polypeptide being
hydrophilic and containing an ATP-binding site (255). A
membrane topology model for CydDC predicted both sub-
units to have six transmembrane regions separated by two
major cytoplasmic loops; both ends of each polypeptide
chain were predicted to be located in the cytoplasm (86).
Subsequent modeling of topography (253) was consistent
with those models, and used to highlight the Walker A motif
(which binds ATP), the Walker B motif (which interacts
with Mg(II)), and conserved amino acids (histidine, gluta-
mate, aspartic acid) that are part of the H-, Q-, and D-loops,
respectively.
The periplasm of an E. coli cydDC knockout mutant is
‘‘overoxidizing’’ (126) indicating that CydDC may catalyze
cell export of reductant(s). Indeed, loss of CydDC diminishes
the level of reduced thiol detected in the extracytoplasmic
compartment, while overexpression of CydDC decreases the
cytoplasmic reduced thiol pool (146). These observations
are consistent with in vitro studies that measured import of
35
S-labeled cysteine into everted membrane vesicles and
demonstrated that, in vivo, CydDC mediates energy-linked
export of cysteine (247).
CydDC also transports outward, and thus presumably
into the periplasm, the tripeptide glutathione (L-c-glutamyl-
cysteinylglycine [GSH]), a major regulator of cellular redox
poise (248). The transport rate for GSH by CydDC was
fivefold higher than for cysteine; therefore, given the abun-
dance of GSH in the bacterial cytoplasm (248), GSH is likely
to be a major substrate for CydDC. Addition of GSH and
cysteine both stimulated the ATPase activity of purified
CydDC (342), supporting an enzymic role in the export of
reductant. The complexity of the process is probably not fully
understood: Eser et al. (110) studied the effects of mutating
three genes (cydD, ggt—encoding periplasmic c-glutamyl
transpeptidase—and mdhA—encoding a multidrug-resistant-
like ABC transporter) that might influence periplasmic GSH
pools, but none affected the ability of glutaredoxin-3 (GrxCp) to
catalyze the formation of disulfide bonds, suggesting the exis-
tence of other routes for GSH export in E. coli.
Because CydDC is an exporter and is required for haem
assembly into the oxidase, it was hypothesized that CydDC
might export haem, a proposal tested experimentally. However,
use of everted vesicles and radiolabeled haem in vitro failed to
demonstrate this function for CydDC (74). Later work
exploited a purified form of CydDC with an absorption peak at
410–412 nm; pyridine haemochrome analyses indicated the
presence of a bound b-type haem with a CydDC:haem ratio
of 5:1 (342). This bound haem was reducible and oxidizable,
and bound CO. Haemin and GSH/cysteine had synergistic
and stimulatory effects on the ATPase activity of the com-
plex. This suggests that the haem cofactor has a significant
but obscure role in CydDC function.
Certain other reduced thiols (including homocysteine and
methionine) also activated CydDC. Control experiments with
S-substituted/nonthiol analogues and haem lacking the cen-
tral iron (protoporphyrin) did not stimulate rates of ATPase
activity, and inclusion of nonthiol reductants decreased the
ATPase rate. These experiments suggest the need for either
thiols or an iron-containing tetrapyrrole in CydDC function.
Histidine was an intriguing exception: it gave a twofold in-
crease in ATPase activity, which increased to eightfold on
additional inclusion of 1 lM haemin. Since axial ligands to
haem include both histidine and reduced thiol compounds,
this suggests that the haem-ligating capacity of reduced thiols
contributes to the enhancements in ATPase activity observed
for GSH and cysteine (342).
3. Structural investigations into the CydDC complex.
Two-dimensional crystals have been obtained by incorpo-
rating purified CydDC into E. coli lipids, thus permitting
cryo-EM (342). The electron densities reveal arrays of di-
meric units in ‘‘up’’ and ‘‘down’’ orientations, indicating
CydDC heterodimers in the crystal lattice. Although no three-
dimensional crystal structure has been reported, Shepherd
and colleagues used a structural modeling approach to study
the roles of individual residues in catalysis and cofactor
binding (253).
The two-point mutations in the earliest cydD1 allele are
G319D and G429E (86). Based on homology modeling, the
G429 residue is close to a conserved aspartate residue; it is
postulated that substitution for a glutamate (also negatively
charged) could disrupt the Walker A motif and abolish
function. Mutation of G319, which was found to be buried at
the bottom of the hydrophobic pocked, may also impact upon
conformational changes during the catalytic cycle [see Poole
et al. (253)].
4. Physiological impacts of CydDC function. Based on
the above data on the effects of CydDC on periplasmic
physiology, the pleiotropic phenotype of cydDC strains may
result predominantly from the disruption of disulfide folding
in that compartment (248). Indeed, sensitivity of the cydDC
mutant to benzylpenicillin was attributed to misfolding of
the disulfide-containing penicillin-binding protein 4. The
observed loss of cell motility in cydDC strains may result, for
example, from a defective P-ring motor protein (247), since
exogenous cystine (i.e., oxidized cysteine) corrects a motility
defect in a dsbB mutant (89). Complementation of cydDC
strains with exogenous reductant largely complemented the
phenotypes associated with defective disulfide folding (248).
It is important to differentiate between deficiencies of
oxidase per se and the additional defects in cydDC mutants,
which do not assemble cytochrome bd. This distinction is
difficult because both cydDC and cydAB mutants display
diverse and sometimes overlapping phenotypes (252). All
cydABmutants (i) appear to lack spectroscopically detectable
cytochrome bd, (ii) fail to survive as robustly as WT cells in
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stationary phase (299), (iii) are sensitive to inhibitors (cya-
nide, azide, Zn(II) ions) (260), and (iv) intolerant of oxidative
and nitrosative stresses (117, 124, 146, 295). cydDC mutants
also exhibit low levels of other cytochromes, particularly
those haemproteins in the periplasm (254), and have a more
oxidized periplasm. The failure of cydDC mutants to export
to the periplasm GSH and cysteine results in a more oxidized
periplasm. However, we do not understand why bd-type
oxidase assembly is inhibited by these defects. Among plau-
sible hypotheses are the following:
 The haems exported by CydDC to the periplasm (74)
may be assembled onto outward-facing domains of the
oxidase subunits. The finding that haem stimulates
the ATPase activity of purified CydDC is intriguing
(Section III.B.2).
 The haems exported by CydDC to the periplasm
CydDC occupy there critical sites such as on chaper-
ones required for oxidase assembly.
 The processing and assembling processes of the peri-
plasm are intolerant of the oxidized nature of the
periplasm in cydDC mutants.
 In addition to GSH and cysteine, which were identified
as substrates for CydDC in transport studies, CydDC
may export other thus-far unidentified metabolites.
We discuss the implications of cytochrome bd deficiency
(and by extension of cydDCmutations) in Sections VI to VIII
and in Poole et al. (253).
5. Conclusions. CydDC is of great interest for its pro-
found impact on oxidase assembly and also because it was the
first heterodimeric ABC-type exporter to be described in
prokaryotes. The genes may or may not be found in an operon
with the structural oxidase genes. The loss of bd-type oxidase
assembly and function in cydDC mutants reveals CydDC to
be crucial for this respiratory complex. The CydDC system
transports to the periplasm reducing molecules, notably GSH
and cysteine, which stimulate the ATPase activity of the
isolated CydDC complex. We lack information on other
potential substrates for CydDC and unambiguous evidence
that haem is transported outward to the periplasm where it
may be assembled into the oxidase. A direct involvement of
haemwith CydDC function is, however, suggested by studies
in vitro of the ATPase activity of CydDC.
IV. Spectral and Redox Properties
The absorption spectra of the three haems, b558 and b595
(which are protohaems IX) and d (which is a cis-haem d hy-
droxychlorin c-spirolactone) constitute the overall absorption
spectrum of cytochrome bd. To date, the E. coli cytochrome
bd-I is the only cytochrome bd for which, by means of spec-
troelectrochemical redox titrations, the difference (reduced
minus oxidized) in spectra of all three haems in the a-, b- (32,
185, 210), and Soret (32) regions was resolved (Fig. 12). The
position of the Soret band maximum for haem b595 is con-
sistent with that unveiled before by femtosecond spectroscopy
(50, 328) and by investigations on the E445A mutant (6, 269).
The spectral contribution of haem d to the aggregated Soret
band is much smaller than those of either b-type haems.
Upper asymptotic redox potentials of haems b558, b595, and
d in the E. coli cytochrome bd-I in sucrose monolaurate at pH
7.0 are +172, +182, and +256mV, respectively (32). These
values are consistent with those for apparent redox potentials
of the haems in bd-type oxidases from E. coli and A. vine-
landii reported earlier (17, 169, 185, 211, 220, 264, 277). The
detergent’s nature affects the apparent redox potentials for
haems b, particularly haem b558, but has virtually no effect
on the haem d potential (32, 211). In the absence of haem d
FIG. 12. Resolved different absorption spectra (reduced minus oxidized) of haems b558, b595, and d in the WT E. coli
cytochrome bd-I in the presence of 50mM n-octyl-b-D-glucoside at pH 7.0. Haem b558 has an a-band at 561 nm, b-band
at 531.5 nm, and the Soret band with kmax = 429.5 nm and kmin = 413 nm. Haem b595 shows an a-band at 594 nm, b-band
at 561.5 nm, a trough at 643 nm reflecting its MLCT band, and the Soret band with kmax = 439 nm and kmin = 400 nm. Haem
d displays an a-band at 629 nm, a trough at 740 nm (its MLCT band), and the Soret band with kmax = 430 nm and
kmin = 405 nm. MLCT, metal-to-ligand charge transfer. Modified from Bloch et al. (32).
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(in the E99L mutant), a large interaction potential (about
-90mV) between haem b558 and haem b595 is observed (32).
The presence of haem d reduces the redox interaction be-
tween the two haems b by ca. three times.
In contrast, redox interaction between haem d and either
b-type haems is weak. The latter apparently contradicts the
fact that the distance between haems b558 and b595 is longer
than that between haems d and b595 (281). However, a strong
redox interaction between redox-active metal sites does not
always mean a short distance between them. Lack of signif-
icant electrostatic interaction at short distance may be due to
screening of the electron charge by the proton taken up on
reduction (32). For instance, in cytochrome c oxidase, the
distance between haem a3 and CuB is much shorter than that
between haem a3 and haem a (154, 322). At the same time,
redox interaction between haem a3 and CuBwas not reported,
whereas the redox interaction between haems a and a3 is
significant (236). Notably, the redox interaction between
haems a and a3 in cytochrome c oxidase (-115mV at pH 8.0)
(128) is significantly larger than that in cytochrome bd-I.
This may be relevant to the proton pumping mechanism in
cytochrome c oxidase (10, 196), although transient states
occurring during the enzyme’s catalytic cycle may not be
accessible in equilibrium redox titrations (300). A possible
redox interaction between semiquinone and the haems in
cytochrome bd remains to be examined, although the mid-
point potential of the bound quinone in cytochrome bd-I was
reported (139).
Being high-spin pentacoordinate, haem d can bind not only
the O2 enzyme natural substrate but also exogenous ligands,
such as CO (7, 34, 37, 38, 44, 50, 52, 54, 142, 143, 165–167,
169, 210, 232, 269, 302–304, 328), NO (34, 41–44, 148, 163,
167, 168), cyanide (34, 167, 177–179, 181, 198, 249, 262,
263, 277, 312, 313, 321), and H2O2 (35, 43, 49, 116, 155, 172,
209, 259). A marginal ligand reactivity of the haems b was
also observed (34, 37, 52, 54, 143, 302). Detailed discussion
of the reactions of cytochrome bdwith the exogenous ligands
is beyond the scope of this review but can be found in Borisov
et al. (48) and Junemann (163).
V. Catalytic Cycle
Whereas the superfamily of haem/copper oxidases com-
prises both quinol and cytochrome c oxidases, the bd-type
oxidases characterized thus far are all quinol oxidases. Unlike
cytochromes c, quinols are two-electron-donating substrates.
Yet, they are oxidized by cytochrome bd through sequential
one-electron transfer steps, with O2 acting as the electron
acceptor (36, 48, 163). Three quinol types with distinct
structural differences can act as physiological substrates for
cytochrome bd: ubiquinol (UQH2), menaquinol (MQH2), and
plastoquinol.
The nature of the quinol substrate can be species-specific
or dependent on growth conditions. For instance, mycobac-
terial and cyanobacterial bd enzymes utilize MQH2 and
plastoquinol, respectively (24, 25, 73, 246), while E. coli
cytochrome bd can use UQH2 or MQH2 depending on O2
availability (24, 25, 246, 323). Interestingly, some cyto-
chromes bd were found to copurify with tightly bound qui-
nols (19, 20), and a structural role in dimer stabilization was
proposed for the UQ8 molecule detected in the recently
solved structure of E. coli cytochrome bd-I (280).
The primary acceptor of electrons donated by the quinol
substrate is haem b558 (Fig. 13). From there, electrons are
transferred intramolecularly to the haems b595 and d, but it is
unclear which of the two other haems is reduced first upon
oxidation of haem b558. The structure of the G. thermo-
denitrificans enzyme (281), with the haems b558 and d sig-
nificantly closer to each other than the two b-type haems
(edge-to-edge distance of 5.9 vs. 8.5 Å, and Fe-Fe distance
of 15.2 vs. 19.4 Å), points to a direct electron transfer from
haem b558 to haem d.
Conversely, the recently solved structure of E. coli bd-I
enzyme (280) with the same triangular arrangement of co-
factors and similar interhaem distances, but interchanged
haems b595 and d, suggests that electron transfer pro-
ceeds along the pathway haem b558 / haem b595 / haem d
(Fig. 13). Despite this uncertainty, in both structures the
haems b595 and d, without forming a binuclear site with their
Fe atoms, are in van der Waals contact (edge-to-edge dis-
tances of 3.5 and 3.8 Å in the G. thermodenitrificans and E.
coli enzyme, respectively). Therefore, regardless of which
haem acts as the primary acceptor for electrons donated by
FIG. 13. Overview of electrogenic pathways in cyto-
chrome bd. The oxidase comprises two major subunits
(CydA, CydB) and a smaller subunit (CydS in G. thermo-
denitrificans, CydX in E. coli). An additional previously
unknown accessory subunit (CydH) was recently revealed in
the E. coli enzyme (280). Electrons donated by the quinol
substrate (QH2) are transferred to haem b558 and from there
to the haems b595 and d, which are in fast redox equilibrium.
Midpoint potentials of the haems of cytochrome bd from
E. coli (32) and G. thermodenitrificans (280) are reported in
mV near the haems. In Safarian et al. (280), the b haems of
the enzyme from G. thermodenitrificans are not assigned but
termed haem bN1 (+50mV) and haem bN2 (+155mV) here,
respectively, assigned to haem b558 and haem b595. The
electron pathway may vary between the G. thermo-
denitrificans and the E. coli enzyme, as they display a
similar haem arrangement, but with exchanged haems b595
and d (280, 281). The O2 reduction to H2O takes place at
haem d. The reaction is electrogenic because protons de-
riving from quinol oxidation are released into the periplasm,
whereas protons required for the O2 chemistry are taken up
from the cytoplasm.
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haem b558, electron equilibration between the haems b595 and
d is expected to be very rapid.
The intramolecular electron transfer processes taking
place inside cytochrome bd are not coupled to a proton
pumping activity (267). Nevertheless (see section III.A),
electron transfer is electrogenic and leads to generation of a
transmembrane electric potential; its existence has been
demonstrated for the enzymes from E. coli and A. vinelandii
with diverse experimental approaches (19, 20, 26, 38, 51,
155, 183, 186, 187, 223, 224, 267). Generation of the
transmembrane electric potential occurs as the electrons are
transferred from haem b558 to the haems b595 and d (19, 20,
38, 155).
The potential arises from uptake and release of protons
during electron transfer, but not from the electron transfer
itself, in line with the information that the three haems are
located at relatively similar depths inside the membrane.
Experimental evidence suggests that the transmembrane
electric potential results from the combined release into the
periplasmic space and uptake from the cytoplasmic space of
protons, respectively, associated with quinol oxidation and
intramolecular reduction of haems b595 and d (19, 20, 38,
155) (Fig. 13). Thus, in the absence of a true redox-coupled
proton pumping activity, combination of these events ac-
counts for a vectorial proton transfer across the membrane,
thereby contributing to the electric potential buildup.
Cytochrome bd in turnover conditions processes O2 to
H2O with a very high affinity for O2. For the E. coli bd-I and
bd-II oxidases, low Km(O2) values were determined, respec-
tively, in the 0.003–0.3 and 0.24–2.0 lM range, depending
on the experimental approach used (16, 88, 156, 217). An
usual feature of cytochrome bd among terminal oxidases is
that in the single-electron reduced state (R1,{), it can bind O2
at reduced haem d to give a stable and spectroscopically
distinct globin-like ferrous-oxy adduct (A1), first identified
by Poole et al. (257). O2 binds reduced haem d in theR
1 state
with high affinity [O2 dissociation constant Kd(O2) of 0.28
and 0.5 lM for the E. coli and A. vinelandii enzyme, re-
spectively (17, 18)], accounting, at least in part, for the low
Km(O2) values displayed by cytochrome bd in turnover [see
Junemann et al. (164) and reference therein].
Interestingly, the single-electron (R1) and three-electron
(R3) reduced states of the enzyme were found to bind O2 at
reduced haem d with remarkably different kinetics (17).
Whereas O2 binding to the R
3 enzyme occurs with rates pro-
portional to [O2], in the case ofR
1, a hyperbolic dependence of
O2 binding rates on [O2] was documented and proposed to
result from an equilibrium between two conformations (called
‘‘open’’ and ‘‘closed’’) with different accessibility of O2 to
reduced haem d (17). This finding suggests that the reactivity of
reduced haem d toward gaseous ligands is modulated by the
redox state of haem b558 and/or haem b595. Consistently, CO
was found to bind and dissociate from haem d in the R1
enzyme more slowly than in the R3 enzyme, and a higher koff
of NO was reported for the R3 enzyme compared with the
R1 enzyme (44, 142, 169, 269).
Binding of O2 to the fully reduced enzyme leads to the
four-electron reduction of O2 to 2H2O via several catalytic
intermediates, which are similar in nature to those populated
in the O2 reaction with haem/copper oxidases. A scheme of
the catalytic cycle is presented in Figure 14. In flow-flash
experiments coupled with spectroscopic or electrometric
measurements, it was found that haem d in the R3 enzyme
binds O2 very rapidly [kon * 2 · 10
9 M-1 s-1 (17, 19, 142)]
and forms a ferrous-oxy species (A3) without generating
electric potential (19, 155). The same species can be observed
immediately after photolysis of the CO-ligated ferrous spe-
cies at temperatures below -100C (257). At room temper-
atures, this is followed by a rapid (s = 4.5 ls) nonelectrogenic
transfer of three or four electrons to the bound O2, respec-
tively, resulting in the formation of either a true peroxy in-
termediate [‘‘P,’’ (19, 38)] or a ferryl species with a radical on
an amino acid or the haem porphyrin [F*, (242)].
Although the detailed chemical nature of this intermediate
remains uncertain, it was noted that the recently solved
structure of the E. coli enzyme does not rule out the occur-
rence of a true P intermediate (280). Regardless of its che-
mical identity, this intermediate (whether P or F*) is rapidly
(s = 47 ls) and electrogenically converted into a nonradical
ferryl F intermediate upon transfer of an additional electron
from haem b558 (19, 20, 38, 155). In the presence of quinol(s)
tightly bound to the enzyme, one or two electrons can be
further transferred rapidly (s = 0.6–1.1ms) to the O2 binding
site, respectively, converting the F intermediate into either a
fully oxidized (O) or a single-electron reduced oxygenated
species (A1), further contributing to generation of the electric
potential (19, 20).
In stopped-flow multiwavelength spectrophotometric ex-
periments, the steady-state level of the catalytic O2 inter-
mediates of cytochrome bd was measured in turnover
conditions sustained with excess dithiothreitol and Q1. Under
these conditions, at steady state, the mostly populated inter-
mediates proved to be the ferryl (F) and oxy-ferrous (A)
species, whereas only a minor portion of the enzyme was
found to be in the O1 state with the electron residing on
haem b558 (45), in accordance with the proposal that the
fully oxidized O species does not take part in the catalytic
mechanism (233, 343).
VI. Physiological Functions
The core functions of terminal oxidases are oxygen re-
duction, generally to water, reductant consumption (in this
case ubiquinol), and proton movements across the mem-
brane, either by proton pumping mechanisms (as in the case
of the haem/copper superfamily) or balanced proton extru-
sion to the outside (periplasm) and uptake from the inside
(cytoplasm), as in the case of cytochrome bd (Fig. 15).
However, in the case of cytochrome bd, we can discern extra
physiological functions or attributes of great interest. These
are summarized at the foot of Figure 15 and described in
detail in the following sections.
A. Respiratory protection of nitrogenase
In addition to its unique structure, characteristic modes of
expression, oxygen kinetics, and resistance to inhibitors
(sections C and VII), cytochrome bd is unusual in being
implicated in a physiological mechanism termed respiratory
protection. This is the maintenance of function of bacterial
nitrogenase, an oxygen-labile enzyme, even under aerobic
{The superscript number denotes the total number of electrons in
the enzyme species.
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conditions, this being attributed to the phenomenal capacity
of cytochrome bd for rapid oxygen consumption.
The free-living obligate aerobe Azotobacter can fix dini-
trogen over a wide range of oxygen concentrations, despite
the notoriously oxygen-sensitive activity of its nitrogenase.
Azotobacter adapts its respiratory rate in response to chang-
ing oxygen tensions (101) and, when fixing nitrogen, has one
of the highest rates of respiration known (256). Dalton and
Postgate proposed that ‘‘uncoupled’’ respiratory activity
might prevent oxygen inhibition of nitrogenase activity (90).
FIG. 15. Overview of the
structure and functions of
the cytochrome bd class of
terminal oxidases. The sim-
plified structure of a three-
subunit, three-haem complex




reduction, and proton trans-
location. Key functions are
shown above the scheme.
Below the scheme are three
major classes of additional
attributes that, collectively,
render cytochrome bd an
important target for thera-
peutic interventions against
bacteria. The fourth small
subunit CydH/Y discovered
in the E. coli cytochrome
bd-I (280, 317) is not shown
for simplicity. Color images
are available online.
FIG. 14. Intermediates generated in the catalytic cycle of cytochrome bd. For each intermediate, the superscript
number indicates the total number of electrons in the enzyme. Oxidized and reduced haems are, respectively, in white
and gray. Bound O2 and its derivatives are in yellow. The intermediates are denoted as follows: R
3, fully (three-electron)
reduced; A3, fully reduced with O2 bound at ferrous haem d; A
1, single-electron reduced with O2 bound at ferrous haem d;
O1, single-electron reduced with ferrous haem b558; O, fully oxidized; P, peroxy. F and F* are both ferryl intermediates, the
asterisk denoting a radical on the haem d porphyrin ring. The shadowed intermediates are those detected at steady state in
Borisov et al. (45).
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The evidence that this involves cytochrome bd is manifold:
(i) the level of the oxidase increases when oxygen supply
increases (e.g., Moshiri et al. (230), but not in E. coli, where
cydAB is expressed maximally at low O2 tensions; see section
II.D); (ii) consumption of carbon and energy sources is par-
tially uncoupled from anabolism, specifically via cytochrome
bd; and (iii) critically, Cyd-mutants cannot fix nitrogen in air
(180). However, a cytochrome bo3 mutant is aerotolerant
during nitrogen fixation (203). The Fnr-like transcription
factor CydR (338, 339) controls the expression of both cy-
tochrome bd and the uncoupled NADH-ubiquinol dehydro-
genase (Ndh) (27), which is thought to supply electrons to
cytochrome bd-I and is also essential for aerotolerant nitro-
gen fixation (28).
The conclusion that cytochrome bd affords respiratory
protection is supported by genetic studies of other bacteria. In
Azorhizobium caulinodans, both cytochrome bd and cyto-
chrome cbb3 contribute equally to nitrogen fixation in root
nodule symbiosis; the double mutant totally lacked symbiotic
N2 fixation (175). InKlebsiella pneumoniae, N2-fixing ability
was severely impaired in a cyd mutant even at low oxygen
concentrations (170).
The hypothesis of respiratory protection, specifically by
cytochrome bd, is widely accepted and the genetic evidence
(i.e., that Cyd-mutants cannot fix nitrogen in air) is viewed as
the most convincing (238). Nevertheless, objections have
been raised. One of these is that total respiratory oxygen
consumption is not elevated above 70 lM O2, where pro-
tection should be most important. However, A. vinelandii
possesses, based on genome interrogation (293), five terminal
oxidases: cytochrome c oxidase (Cdt), cytochrome o (Cox),
cytochrome bd copy I (CydAB I), cytochrome bd copy II
(CydAB II), and cytochrome cbb3 (Cco).
Note that the mutagenesis approach in Kelly et al. (180),
which is taken as the best evidence for respiratory protection,
was targeted at cytochrome bd-I. The presence of multiple
oxidases allows flux through different branches, only one
of which terminates in cytochrome bd-I, to be redistributed
during protection of nitrogenase without elevation of total
respiratory rates. A second concern is that the efficiency of
respiration in protection may be insignificant because the rate
of consumption is too low to prevent diffusion of O2 into cells.
However, the location of the O2-reducing site deep within the
oxidase structure may block O2 access to the cytoplasm.
Clearly though, unanswered questions remain regarding
the details of the mechanisms, and other factors (intracellular
redox state, ATP provision for nitrogenase, and O2 control of
nitrogenase) might be important. Note, however, that ‘‘un-
coupled’’ respiration (i.e., respiration that is not coupled to
PMF generation) is not an essential requirement of the pro-
posed mechanism, which is only that cytochrome bd-
supported oxygen uptake uniquely provides the protection.
Other mechanisms probably play roles: thus, the alginate
capsule of A. vinelandii is affected by oxygen tension and
could create a barrier to the entry of oxygen (279). However,
the genetic data do appear to provide the evidence required by
Oelze (238) for the hypothesis of respiratory protection.
B. An oxygen-reactive oxidase in anaerobes?
Anaerobic microbes are sometimes defined as those that
cannot grow at dissolved oxygen concentrations greater than
5 lM; however, many ‘‘anaerobes’’ survive at such levels.
B. fragilis colonizes the colon, even in the absence of fac-
ultative anaerobes that could maintain low oxygen concen-
trations, and grows at oxygen concentrations around 300 nM.
B. fragilis encodes a cytochrome bd-type oxidase and con-
sumes oxygen at appreciable rates, but a DcydABmutant was
defective in oxygen uptake (13). In this organism, and in
many prokaryotes that have been classified as strict anaer-
obes, cyd genes are widely distributed; these bacteria include
Methanosarcina, Archaeoglobus, Moorella, and Geobacter
species (13, 92, 205). The term ‘‘nanaerobes’’ has been
coined to describe such bacteria that can benefit from, but do
not require, oxygen for growth (13).
In the case of facultative anaerobes such as E. coli, survival
in low-oxygen environments, such as the mammalian intes-
tine, depends on the organism’s respiratory flexibility and in
particular the presence of cytochrome bd. Mutants lacking
cytochrome bd fail to colonize (159, 160). Expression of
genes in E. coli that encode the oxidases and other respiratory
chain complexes has been widely studied, and recently in the
context of systems biology [for reviews see Bettenbrock et al.
(30) and Ederer et al. (104)].
In brief, there occurs a progressive switch to aerobic re-
spiratory metabolism and a remodeling of the cell envelope as
oxygen availability increases (276, 319). Maximal levels of
cytochrome bd occur at intermediate levels of oxygen supply,
that is, at a point approximately midway between anaerobiosis
and the onset of aerobic metabolism as inferred from acetate
excretion during glucose metabolism (276). In contrast, the
cyoABCDE operon was maximally expressed under fully
aerobic conditions: changes in abundance of the cydAB and
cyoA–E transcripts were reflected cellular contents of cyto-
chrome bd and cytochrome bo3, respectively, consistent with
the previously measured oxygen affinities. Cytochrome bd-II
is also operative under limiting oxygen conditions (309).
Oxygen reduction is widespread in sulfur-reducing bacte-
ria including some Desulfovibrio species (91) and supports
chemiosmotic energy conservation (100). Although classified
as an anaerobe, D. gigas contains a functional membrane-
bound respiratory chain, including a canonical cytochrome
bd quinol oxidase as its terminal enzyme (202, 215). Lemos
et al. (202) demonstrated that membranes from D. gigas re-
duce oxygen to water and isolated a two-subunit oxidase of
the cytochrome bd family, with spectral properties similar to
other such oxidases. With NADH or succinate as electron
donors, specific oxygen uptake activities were comparable
with those of aerobes. Surprisingly, the expression levels of
the oxidase were unaffected by 60lM O2, but modest upre-
gulation was noted in the presence of 150lM NO (215).
Other established anaerobes such as D. vulgaris respond
to 0.1% oxygen exposure at the transcriptomic and pro-
teomic levels (231). The genome sequence (140) indicates
the presence of two oxidases: a cytochrome c oxidase and
cytochrome bd. Both were confirmed by hybridization
experiments with CoxA and CydA probes and further se-
quence analysis (288). The presence of cydAB genes in
D. vulgariswas later confirmed and this oxidase shown to be
more highly expressed than the cox operon encoding a
cc(o/b)o3-type oxidase (199). The oxygen affinity of the
bd-type oxidase (Km = 600 nM) was measured polaro-
graphically (268); however, such measurements probably
overestimate the Km value (88).
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What are the roles of such oxidases in ‘‘anaerobes’’?
Plausible hypotheses include the following: (i) scavenging of
O2 for protection against the damaging effects of oxygen, (ii)
ATP gain for survival aerobically in changeable habitats, and
(iii) catalyzing a rapid, ‘‘uncoupled’’ electron transfer and
burning excess reducing substrates. These functions may
have long histories: phylogenetic analyses suggest that the
Aquificae phylum is one of the earliest diverging phyla of
Eubacteria for which sequence data are available and indicate
that cytochrome bd was present in the most ancient Eu-
bacteria (13). This is consistent with the view that sufficient
oxygen to support respiration predated the photosynthesis-
derived appearance of abundant oxygen on Earth.
C. Environmental stressors and their relationships
with cytochrome bd
1. Peroxide. Cytochrome bd may contribute to protec-
tion against H2O2-induced stress. Mutant E. coli cells lacking
cytochrome bd (126, 206, 329) showed high susceptibility to
H2O2, and the same was shown for some pathogenic bacteria
(14, 295). Consistently, addition of exogenous H2O2 (206) or
endogenous production of ROS increased cytochrome bd
expression (67). This protective role of cytochrome bd is not
exclusive to E. coli [see Giuffre et al. (124) and references
therein]. Hypersensitivity to H2O2 or enhanced ROS pro-
duction has been described also for other bacteria deficient in
this oxidase (106, 340), including bacterial pathogens that
inhabit microaerobic environments and are exposed to the
ROS produced by the host immune system (107, 201, 212) or
as a result of antibiotic treatments (212).
Accordingly, upon exposure to H2O2, an upregulation of
cytochrome bd was documented in Staphylococcus aureus
(66) and in Mycobacterium tuberculosis, where a catalase-
independent hyper-resistance to H2O2 was also observed
(305). When anaerobic cultures of an E. coli strain devoid of
the antioxidant enzymes KatG, KatE, and Ahp are abruptly
aerated, cytochrome bd is able to reduce intracellular H2O2
production (191), suggesting that the oxidase serves as an
electron sink by diverting electrons from a fumarate reduc-
tase, a major H2O2-generator.
Moreover, E. coli cytochrome bd-I was shown to be capable
of detoxifying H2O2 directly (Fig. 16). A high catalase activity
was observed in both the isolated untagged bd-I enzyme and in
catalase-deficient cells overexpressing cytochrome bd-I (40,
114). Cytochrome bd-I also shows peroxidase activity (1, 39,
182), particularly in the His-tagged enzyme with decyl-
ubiquinol as the electron donor (1). The latter preparation,
however, displays no catalase activity (1). The issue is dis-
cussed in Forte et al. (117). It remains to be established whether
the H2O2-metabolizing ability is unique to the E. coli enzyme
or is a common property of bd-type oxidases.
2. NO and ONOO-. NO and the product of its reaction
with superoxide radical (O2
-), ONOO-, are produced by the
host as part of the immune response to kill invadingmicrobes.
Cytochrome bd is involved in protection of bacteria against
stress caused by these RNS. Transcriptional upregulation of
genes encoding cytochrome bd has been observed in response
to NO exposure in E. coli (150, 265) and in other bacteria
(215, 229, 273, 296). NO induces greater growth inhibition in
cytochrome bd-deficient E. coli strains, compared with cy-
tochrome bo3-deleted mutants (217). The effect is observed
in mutants of both the cytochrome bd-encoding cydAB genes
and the cydDC genes (146).
Similar observations were made in cytochrome bdmutants
of uropathogenic E. coli (14, 295). Cytochrome bd also pro-
tects Salmonella enterica against NO toxicity thereby en-
hancing its virulence (161). Like cytochrome c oxidase (289,
290), cytochrome bd is potently but reversibly inhibited by
NO [IC50*0.1lMNO at 70lMO2 (42)]. Such inhibition was
shown both with E. coli cells (217, 310) and with cytochrome
bd isolated from E. coli or A. vinelandii (42). NO reacts with
haem d: when haem d is ferrous, oxy-ferrous, or ferric, the
end-product is nitrosyl (41, 42, 44), whereas reaction of the
ferryl haem d with NO yields nitrite (43) (Fig. 17). Due to an
unprecedentedly high off-rate of NO from the ferrous haem d,
reversal of cytochrome bd inhibition is much faster than with
cytochrome c oxidase (42, 44, 217), explaining why cyto-
chrome bd confers NO resistance to bacteria.
A further reason could be that ferryl cytochrome bd, a highly
populated intermediate in turnover (45), converts NO into less
toxic nitrite at a rate *10 times higher than that of the analo-
gous reaction of the ferryl cytochrome c oxidase (43).
ONOO- was reported to irreversibly inhibit cytochrome c
oxidase (294), whereas E. coli cytochrome bd-I is highly
resistant to inhibition (47). Furthermore, cytochrome bd-I can
metabolize this harmful RNS with an apparent turnover rate
of *10mol ONOO- (mol enzyme)-1 s-1, thereby playing a
protective role against ONOO- damage.
3. Sulfide. Sulfide potently inhibits cytochrome c oxi-
dase, leading to energy depletion and cell death (76, 235, 244,
315). As many bacteria synthesize H2S and inhabit sulfide-
rich environments, such as the human colon, they may be
endowed with a sulfide-insensitive oxidase, other than
FIG. 16. E. coli cytochrome bd-I is proposed to have
catalase [(40), top] or quinol peroxidase activity [(1),
bottom].
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cytochrome c oxidase. This hypothesis was tested on E. coli
reaching the conclusion that such an oxidase is cytochrome bd
(115, 192). Forte et al. found that whereas sulfide is a potent
inhibitor of cytochrome bo3 (IC50 * 1.1lM), both cyto-
chrome bd-I and cytochrome bd-II of E. coli are insensitive to
sulfide up to 58lM (115).
Furthermore, in E. colimutants, O2 respiration and growth
are impaired by sulfide when respiration is sustained by cy-
tochrome bo3 alone, but unaffected by up to 200 lM sulfide
when bd-I or bd-II acts as the only terminal oxidase. Simi-
larly, Korshunov et al. reported that in a cytochrome bd-
deficient mutant, both O2 respiration and growth are inhibited
by sulfide, exogenously administered or endogenously gen-
erated from cysteine (192). The sulfide insensitivity of cy-
tochrome bd is possibly due to the lack of a copper site, since
inhibition of cytochrome c oxidase by sulfide is thought to
involve a transient binding of H2S to CuB (235).
Based on these data, it was postulated that the sulfide
tolerance provided by cytochrome bd can play a role in
shaping the composition of human intestinal microbiota, thus
impacting human physiology and pathophysiology (62). In-
terestingly, upregulation of the cytochrome bd-I and bd-II
genes was observed in E. coli cells following addition of an
H2S donor, alone or in combination with the antibiotic am-
picillin, indicating that expression of the sulfide-insensitive
oxidases enables bacterial respiration under antibiotic-
induced oxidative stress (298). Indeed, E. coli mutant strains
lacking bd-type oxidase fail to colonize the mouse intestine,
contrary to those lacking bo3-type oxidase (159).
4. Chromate. Cytochrome bd has been recently shown
to contribute to chromate resistance in Alishewanella
sp. WH16-1 (340), a facultative anaerobic bacterium isolated
from the soil of a copper and iron mine. This strain efficiently
reduces sulfate to sulfide and the toxic hexavalent chromate
Cr(VI) to the much less toxic Cr(III), thus showing a great
potential for chromate bioremediation. Cr(VI), mainly pro-
duced by human activities, is considered a severe pollutant
and a serious threat to human health, being mutagenic and
carcinogenic. The high toxicity of Cr(VI) is linked to its ability
to enter the cells and exert a strong oxidizing power. The
structural similarity with sulfate allows Cr(VI) to cross the
cellular membrane via sulfate transporters (80, 326) and,
once in the cell, to generate ROS (306, 326).
Cytochrome bd confers bacterial resistance to chromate
by decreasing chromate-induced cellular oxidative stress
and allowing sulfide-dependent chromate reduction (340). In
Alishewanella sp. WH16 WT and cytochrome bd mutant
strains, the addition of millimolar K2CrO4 resulted in a higher
H2O2 production in cytochrome bd-deficient cells compared
with the WT or the cytochrome bd-complemented strain,
suggesting a role for Alishewanella cytochrome bd in H2O2
detoxification, as also shown for the E. coli oxidase (1, 40).
Furthermore, in H2O2 inhibition zone tests, the mutant
strain was more sensitive to exogenous H2O2 than was the
WT. Since sulfide can be used as a reductant to reduce
chromate to less toxic forms, the effect of Na2S on cell
growth was also investigated. Whereas growth of the WT
cells was unaffected by the presence of 200lM sulfide in the
culture medium, the cytochrome bd-deficient strain was
completely inhibited under these conditions. Thus, the cy-
tochromes bd of both Alishewanella Sp. WH16-1 and E. coli
(115) contribute to resistance to sulfide and, indirectly, also to
chromate. Summing up, cytochrome bd contributes to the
remarkably lower minimum inhibition concentration (MIC)
for chromate, as well as the ability of WT strains to reduce
chromate to less poisonous forms (340).
VII. Antibiotics and Antimicrobial Agents
A. Cationic amphiphilic peptides
with antimicrobial activities
Cationic amphiphilic peptides with antimicrobial activities
can be divided into two major classes: nonribosomally and
FIG. 17. Reactions of cyto-
chrome bd species with NO. A1
reacts with NO after O2 dis-
placement yielding the single-
electron reduced species (R1).
The reaction with the A1 interme-
diate is thus rate limited by O2
dissociation. The R1 and R3 spe-
cies react with NO quickly, yield-
ing a nitrosyl ferrous (Fe2+–NO)
adduct. NO dissociates from R3
species fourfold faster than from
R1. The O species reacts with NO,
yielding a nitrosyl ferric (Fe3+–NO
4 Fe2+–NO+) adduct. The reac-
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ribosomally synthesized peptides (134, 237). Both classes
typically further undergo maturation and chemical modifi-
cations. Nonribosomally synthesized peptides are produced
only in bacteria and fungi. The biosynthesis of these pep-
tides proceeds on multifunctional peptide synthetases in an
RNA-independent manner following the multiple carrier
thiotemplate mechanism (308). The synthetases have a mod-
ular organization, and these modules interact in an ordered
manner to produce the peptide product (327). Gene-encoded
ribosomally synthesized peptides are produced by all species
and can be further subdivided into bacteriocins (produced by
bacteria), archaeocins (produced by Archaea), and antimicro-
bial peptides (produced by eukaryotes) (216, 237).
Bacteria use cationic amphiphilic peptides to kill or limit the
growth of competitors that occupy the same ecological niche. In
higher organisms, antimicrobial peptides are part of the innate
immune response. The peptides are thought to kill bacteria pri-
marily due to their interaction with bacterial membranes or
cell walls. Permeabilization of the microbial membrane lipid
bilayer is a commonly acceptedmechanism of their action, since
the peptides usually have a net positive charge and a high ratio of
hydrophobic amino acids. These properties enable the peptides
to selectively bind to negatively charged bacterial membranes
leading to nonenzymatic membrane disruption (347).
However, a growing body of evidence suggests that cat-
ionic amphiphilic peptides can have other molecular targets.
One such target could be a bd-type terminal oxidase. Indeed,
E. coli cytochrome bd-I is targeted by several peptides tested,
such as gramicidin S, cathelicidin LL-37, and microcin J25
(MccJ25) (Fig. 18). Thus, cytochrome bd-I would hardly
contribute to bacterial defense against these peptides but ra-
ther serves as a mediator of their action.
1. Gramicidin S. Gramicidin S (‘‘Soviet’’) is non-
ribosomally produced by the gram-positive soil bacterium An-
eurinibacillus migulanus. This is a cationic cyclic decapeptide
made up of two identical pentapeptides joined head-to-tail
with the primary structure [cyclo-(Val-Orn-Leu-D-Phe-Pro)2].
The peptide has an antiparallel b-sheet arrangement stabilized
by two type II¢ b-turns and four intramolecular hydrogen bonds
(149). Such a secondary structure makes the molecule am-
phiphilic that is probably essential for bioactivity. Gramicidin
S at lM concentrations is active against gram-negative and
gram-positive bacteria, fungi, viruses, and single-cell patho-
genic eukaryotes (189). While the mechanism of cytotoxic
activity of gramicidin S is still a matter of debate, the primary
mode of its action is thought to be disruption of the integrity of
the plasma membrane phospholipid bilayer. This leads to the
increase in membrane permeability, dissipation of the mem-
brane potential, and cell death (109).
It was shown recently that gramicidin S is a potent inhib-
itor of both membrane-bound and purified E. coli cytochrome
bd-I (228). On the contrary, the naturally producedmixture of
gramicidins A, B, and C, denoted collectively as gramicidin
D, which are linear pentadecapeptides forming dimeric cat-
ionic channels, does not inhibit cytochrome bd. E. coli cyto-
chrome bo3 and cyanide-insensitive quinol oxidase (CioAB)
from Gluconobacter oxydans appeared to be one-order of
magnitude less sensitive to gramicidin S. Although sub-
micromolar concentrations of gramicidin S moderately stim-
ulate the ubiquinol-1 oxidase activity of cytochrome bd-I, at
higher peptide concentrations, cytochrome bd-I is inhibited.
Upon preincubation of cytochrome bd-I with gramicidin S,
IC50 values are in the range of 2.6–5.4lM.
These values are consistent with the minimum inhibitory
concentration (MIC) of E. coli cells (4–16 lM) (190), as well
as IC50 values for 2-heptyl-4-hydroxyquinoline N-oxide
(1 lM), antimycin A (5lM), and piericidin A (10lM), quinol
oxidation site inhibitors (227, 228). This is thought to be
mixed-type inhibition, decreasing the apparent Vmax and the
affinity for substrates (228). Gramicidin S does not affect the
spectral properties of cytochrome bd-I in the air-oxidized and
fully reduced states. The authors conclude that the E. coli
cytochrome bd-I is a bacterial membrane target for the pep-
tide, whereas according to current thinking, the principal
target of gramicidin S is the lipid bilayer rather than any
membrane protein. The underlying mechanism of inhibition
may be an alteration of the cytochrome bd-I structure via
binding to its hydrophobic surface.
2. Cathelicidin LL-37. Cathelicidins, along with de-
fensins, are the two main families of ribosomally synthesized
antimicrobial peptides, effector molecules of the innate im-
munity of mammals (318). Cathelicidins have a highly con-
served N-terminal cathelin domain and a variable C-terminal
antimicrobial domain. The latter can be released from the
precursor peptide after protease cleavage. LL-37 is an active
37-residue a-helical C-terminal domain of the only human
cathelicidin identified to date. The primary structure of LL-37
is LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
(158). This 18-kDa propeptide is denoted as hCAP-18
(human cationic antimicrobial protein).
Recently, it was reported that cathelicidin LL-37 shows a
fourfold lower MIC against E. coli in aerobic growth com-
pared with under anaerobic or fermentation conditions (4 vs.
16 lM) (69). Thus, the MIC data suggest that the inhibition of
E. coli growth by LL-37 is mediated by oxygen. In aerobic
FIG. 18. Possible effects of cationic amphiphilic pep-
tides with antimicrobial activities on E. coli cytochrome
bd-I. Gramicidin S, microcin J25, and possibly cathelicidin
LL-37 inhibit cytochrome bd-I. In addition, microcin J25
and cathelicidin LL-37 make cytochrome bd-I a site of su-
peroxide (O2
-) production (69, 118, 119, 228).
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growth conditions, LL-37 induces oxidative stress within
seconds of contact with E. coli. To monitor oxidative stress,
real-time, single-cell fluorescence imaging with the dyes
CellROX Green and Amplex Red was used. ROS formation
occurs after entry of LL-37 into the periplasm, but before
permeabilization of the cytoplasmic membrane. Entry of the
peptide into the periplasm gives it access to the outer leaflet of
the cytoplasmic membrane and to external surfaces of cyto-
plasmic membrane proteins. Strong oxidative signals require a
robust transmembrane potential and correlates with the lower
MIC in aerobic, compared with anaerobic, growth conditions.
These observations imply that LL-37 affects the aerobic
respiratory chain, disrupting electron flow. In aerobic E. coli
cultures, the peptide-induced oxidative signals are attenuated
in the cytochrome bd-I mutant but not in a cytochrome bo3
mutant (69). This suggests that LL-37 targets cytochrome
bd-I, but not cytochrome bo3, leading to release of ROS, most
likely O2
-, into the periplasmic space. The LL-37 action
may be based on its direct interaction with cytochrome bd-I,
for instance, due to electrostatic binding. Alternatively, being
polycationic (net charge +6), LL-37 may impair cytochrome
bd-I function indirectly by perturbation of the lipid envi-
ronment, for example, via strong interaction with the annular
anionic phospholipids such as cardiolipin or phosphati-
dylglycerol. The authors (69) propose that the host can use
the degree of tissue aeration for selective control of the po-
tency of LL-37 and possibly other antimicrobial peptides.
3. Microcin J25. Microcins are ribosomally synthesized
bacteriocins produced by E. coli and related enterobacteria.
MccJ25 belongs to class I microcins. This is a plasmid-encoded,
posttranslationally modified, 21-residue lasso-peptide. The
peptide is composed of the N-terminal macrolactam ring and
the C-terminal tail. The ring consisting of eight amino acid
residues is formed by a lactam bond between the first and
eighth amino acids. The ring is threaded and trapped by the
C-terminal tail of 13 residues forming a lasso (271). MccJ25
targets essentially foodborne pathogens, such as E. coli,
Shigella flexneri, and Salmonella enterica serotypes New-
port, Enteritidis, Heidelberg, and Paratyphi B (118).
To cross the outer membrane of a sensitive bacterium,
MccJ25 uses the Trojan horse strategy. The peptide is thought
to hijack FhuA, an outer-membrane transporter for Fe3+
chelated to the siderophore ferrichrome (285). The process
requires a PMF that is transduced to FhuA by the inner
membrane-anchored TonB–ExbB–ExbD complex. When in
the periplasmic space, MccJ25 is proposed to interact with
the inner membrane protein SbmA to cross the inner mem-
brane (286). Once in the cytoplasm,MccJ25 inhibits bacterial
transcription via interaction with RNA polymerase (RNAP).
The peptide binds to the RNAP secondary channel that di-
rects ribonucleotide precursors toward the active site, thereby
blocking its operation in a cork in-the-bottle manner (271).
The other targets of MccJ25 are respiratory chains of
sensitive bacteria. Although the inhibition mechanism is not
yet completely clear, it was reported that the peptide can
inhibit the activity of respiratory chain complexes and en-
hance O2
- production (21).
Recently, Galvan et al. examined the effect of MccJ25 on
the properties of the E. coli terminal oxidases using bacterial
cells, membranes (119), and the isolated enzymes (118). It
was shown that E. coli mutant strains lacking cytochrome
bd-I or cytochrome bo3, in which the entry of MccJ25 is
facilitated by overexpressing FhuA, are less sensitive to
MccJ25 than the WT (119). The MIC of MccJ25-GA (a
variant of MccJ25 in which the C-terminal carboxyl group is
blocked with an L-glycine methyl ester that leads to the loss
of its ability to interact with RNAP) for an E. coli cytochrome
bd-I mutant increases 16-fold compared with WT. In the
presence of MccJ25, membranes of the E. coli mutant ex-
pressing cytochrome bd-I as the only respiratory oxidase
show significant ROS overproduction. The ROS overpro-
duction observed with the membranes, however, is not seen
with whole cells, possibly because detoxifying enzymes in
the cytosol rapidly quench the ROS produced.
Membranes of the E. coli mutant expressing cytochrome
bo3 as the only respiratory oxidase show no ROS overpro-
duction in the presence of MccJ25. Galvan et al. concluded
that MccJ25 affects E. coli cytochrome bd-I making it a
major site of O2
- production. Interestingly, while the Dbo3
and Dbd-I mutants become less sensitive to the peptide
compared with the WT, in the Dbo3/Dbd-II and Dbd-I/Dbd-II
double mutants, recovery of the original, WT-like sensitivity
to MccJ25 and MccJ25-GA is observed. This observation
allowed the authors to suggest that E. coli cytochrome bd-II
may protect the cell from the deleterious effects of MccJ25
and MccJ25-GA (119). The protection could be achieved by
ROS detoxification, but further investigation is required.
The inhibitory action of MccJ25 on enzymatic oxygen
consumption was studied in detail with the isolated E. coli
quinol oxidases, bd-I and bo3 (118). MccJ25 was found to
inhibit the ubiquinol-1 oxidase activity of cytochrome bd-I
with an IC50 of 76lM. This is accompanied by a decrease in
Vmax, but Km for ubiquinol-1 does not change significantly.
Based on these effects of the peptide on the kinetic parameters,
the authors proposed thatMccJ25 inhibits cytochrome bd-I in a
noncompetitive way (118). The influence of MccJ25-GA on
the cytochrome bd-I activity appears to be similar to that of
MccJ25. In contrast, the cytochrome bo3 activity is not af-
fected by MccJ25, and Vmax and Km for ubiquinol-1 with and
without peptide are not significantly different. When the iso-
lated cytochrome bd-I is treated with MccJ25 or MccJ25-GA,
ROS generation initiated by the addition of ubiquinol-1 in-
creases by 39% or 31%, respectively.
Since superoxide dismutase suppresses ROS production, it
was concluded that the generated species is O2
-. Neither
MccJ25 nor MccJ25-GA increases ROS production by the
isolated cytochrome bo3. The addition of MccJ25 to the air-
oxidized cytochrome bd-I in the presence of 6mM KCN in-
duces absorption changes corresponding to the reduction of
haem b558 and the displacement of bound O2 from haem d
2+.
Treatment of cytochrome bo3 with MccJ25 and cyanide
causes no spectral change. Thus, the peptide can reduce cy-
tochrome bd-I. This is consistent with the fact that MccJ25 is
a redox-active peptide capable of forming a long-lived tyr-
osyl (Tyr9) radical (64).
However, it is still not clear whether the peptide-induced
change in the oxidation state of cytochrome bd-I is related to
its inhibitory action. It is possible that the binding of MccJ25
to the bd-I oxidase slows the rate of intraprotein electron
transfer, for instance, by affecting quinol oxidation via con-
formational change in the protein. This could lead to the
release of O2
-, fast enough to compete with electron transfer
to the oxygen-reducing site to form H2O. It is clear, however,
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that to have a significant inhibitory effect on both RNAP
and the respiratory chain, the peptide should accumulate to
high levels in the sensitive bacterial cell.
B. Other antimicrobial compounds
Cytochrome bd appears to be involved in the defense of
mycobacteria against antibiotic-induced stress. Targeting the
respiratory chain enzymes is now considered a new promis-
ing strategy for fighting multidrug-resistant, extensively
drug-resistant, and totally drug-resistant strains of Myco-
bacterium tuberculosis (11, 72, 136). As for most bacteria,
M. tuberculosis has a branched respiratory chain (71, 73).
Electrons are transferred from the type II NDH or other de-
hydrogenases to the MQ pool, and then to O2 through either
the bcc-aa3 supercomplex, formed by cytochrome bcc (a
variant of the bc1 complex) and cytochrome aa3, or cyto-
chrome bd (11, 72, 136, 152). The PMF thus generated
powers of ATP synthesis by the ATP synthase.
1. Bedaquiline. Bedaquiline (BDQ; Sirturo), a dia-
rylquinoline compound (Fig. 19), was the first drug approved
by the FDA and EMA that targets M. tuberculosis energy
metabolism. It selectively inhibits the M. tuberculosis ATP
synthase by binding to the c-ring rotor of its Fo subcomplex
(4, 193, 261). As a result, ATP synthesis is inhibited and
intracellular ATP levels decrease significantly (193, 194).
The inhibition mechanism is possibly based on the ability of
BDQ, upon its localization at the ATP synthase, to create an
uncoupled microenvironment by acting as an H+/K+ iono-
phore that causes dissipation of transmembrane pH and po-
tassium gradients (137). The activity of BDQ appears to be
specific for mycobacteria and is not observed with non-
mycobacterial strains (4).
In mammalian cells, the compound affects neither the mi-
tochondrial ATP synthase (133) nor the membrane potential
(112). Killing ofM. tuberculosis byBDQ is not concentration-
but time-dependent, its bactericidal activity showing a de-
layed onset (195). The rate ofM. tuberculosis H37Rv killing,
however, is increased by 55% if cytochrome bd is mutated by
replacing the cydA gene with a hygromycin cassette via spe-
cialized transduction (23).
While BDQ is bactericidal against M. tuberculosis, it is
bacteriostatic against the nonpathogenicM. smegmatis (4). If
the cydA gene is disrupted, susceptibility ofM. smegmatis to
BDQ increases (138) and the drug becomes bactericidal
(212). Accordingly, both M. tuberculosis and M. smegmatis
WT cells treated with BDQ show a marked increase in cy-
tochrome bd expression levels (138, 195).
2. Clofazimine. Figure 19 shows the riminophenazine
derivative clofazimine (CFZ) (12), a well-known antilep-
rosy drug. The drug can also undergo reduction with NADH
FIG. 19. Structures of antimicrobial compounds reported in section VII.B. Shown are BDQ (4), CFZ (12), INH
(270), telacebec (Q203) (245), TB47 (213), LPZ (278), PAB compound 54 (65), and arylvinylpiperazine amide
compound AX-35 (113). BDQ, bedaquiline; CFZ, clofazimine; INH, isoniazid; LPZ, lansoprazole; PAB, phenoxyalk-
ylbenzimidazole; TB47, pyrazolo[1,5-a]pyridine-3-carboxamide.
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catalyzed by NDH-2. Reduced CFZ is unstable and sponta-
neously oxidized by O2, producing ROS (344). As NADH is
continually produced in the Krebs cycle and fatty acid
b-oxidation, the redox cycling of CFZ will continually run.
The viability of the M. smegmatis cydA mutant is strongly
reduced in response to CFZ compared with WT strains (212).
3. Isoniazid. Isoniazid (INH) (Fig. 19) is a first-line
bactericidal antituberculosis drug that inhibits the biosyn-
thesis of mycolic acids, the core components of the myco-
bacterial cell wall (270). Its activity, however, is reduced
significantly under stress conditions, such as low aeration
(335) and nutrient starvation (31). This indicates that the
bactericidal effects of INH may not be due only to inhibition
of the known target. INH rapidly increases ATP levels and
oxygen consumption, and dissipates membrane potential in
Mycobacterium bovis BCG. The fact that Q203 and BDQ
compromise INH-mediated ATP increase and bactericidal
activity suggests that a killing mechanism of INH involves
perturbation of the mycobacterial respiratory chain (346).
Indeed, M. tuberculosis mutants defective in cydC essential
for cytochrome bd assembly appeared to be more susceptible
to INH in mice (99).
Accordingly, inhibition of cytochrome bd by aurachin D
significantly reduces cell recovery in a culture settling model
(346). This points to a contribution of cytochrome bd in
protection against INH stresses such as hypoxia (346). In-
terestingly, the rate of ROS production increases in INH-
treated mycobacterial cell extracts (297), and disruption of
superoxide dismutase A increases INH sensitivity (103). If
INH induces ROS by interacting with the respiratory chain,
cytochrome bd could protect mycobacterial cells against the
drug via ROS detoxification.
Thus, protection against CFZ, BDQ, and INH provided by
cytochrome bd may be related to the ability of the oxidase to
scavenge and/or prevent generation of ROS [e.g., see Al-
Attar et al. (1), Borisov et al. (39), Borisov et al. (40), Forte
et al. (114)] induced by the drugs (Fig. 20).
4. Cytochrome bd protection of mycobacteria from com-
pounds targeting cytochrome bcc. Another drug targeting
the M. tuberculosis respiratory chain is Q203 (Fig. 19), now
designated telacebec by its developer, Qurient Co., Ltd. This
imidazopyridine amide (IPA) compound and a clinical-stage
drug candidate inhibit cytochrome bcc by binding to the
quinol oxidation site (Qp) in the cytochrome b (QcrB) subunit
(245). However, Q203 is only bacteriostatic and does not kill
the drug-tolerant persisters because, following bcc inhibition,
electron flow rerouting to cytochrome bd is sufficient to
support sufficiently high oxidative phosphorylation and pre-
vent Q203-induced death (173). Accordingly, while the
growth of most M. tuberculosis clinical strains is fully in-
hibited by IPAs, the laboratory-adapted strains H37Rv,
CDC1551, and Erdman can overcome this growth inhibition
by upregulating the cydA gene, whose deletion makes the
H37Rv strain highly susceptible to IPAs (5). The potency of
Q203 is modulated by carbon catabolism and the composition
of the culture broth medium (174). It is alleviated by glycerol
supplementation that correlates with the overexpression of
the cydABDC operon. The cydAB deletion annuls the detri-
mental effect of glycerol on the efficacy of Q203.
A study in a mouse model of tuberculosis reveals a pow-
erful synthetic lethal interaction between cytochrome bcc and
cytochrome bd (173). A synthetic lethal interaction refers to a
type of genetic interaction where the single inactivation of
two genes affects cell viability only slightly, whereas their
simultaneous inactivation causes lethality (349). This also
includes the case when the combination of a mutation and
treatment with a chemical compound results in cell death,
while the mutation or compound treatment alone is nonlethal.
Simultaneous inactivation of both mycobacterial respiratory
oxidase complexes (via genetic deletion of the cydAB genes
and chemical inhibition of cytochrome bcc by Q203) results
in complete inhibition of respiration, killing of phenotypic
drug-tolerant persisters, and rapid eradication of M. tuber-
culosis infection in vivo (173). Thus, at least in the mouse
lung microenvironment, the ability of M. tuberculosis to
multiply and persist is dependent on oxygen respiration.
Mycobacterium ulcerans is known to be the causative
agent of Buruli ulcer, a chronic, necrotizing disease that
affects the skin and sometimes bone leading to permanent
disfigurement and long-term disability. Due to a nonsense
mutation in the cydA gene, cytochrome bd is inactive in all
classical M. ulcerans strains. This makes cytochrome bcc
the only functional terminal electron acceptor in their re-
spiratory chain. As a result, Q203 becomes bactericidal at
low dose against these strains both in vitro and in a mouse
model. The drug could thus simplify and shorten Buruli
ulcer treatment (292).
Figure 19 also shows other compounds targeting QcrB of
theM. tuberculosis cytochrome bcc. These are pyrazolo[1,5-
a]pyridine-3-carboxamide (TB47) (213), lansoprazole
(278), phenoxyalkylbenzimidazoles (29, 65), and the ar-
ylvinylpiperazine amide (AX) series AX-35 and four related
analogues (AX-36 to AX-39) (113). The compounds are
bacteriostatic rather than bactericidal in their action. This is
probably due to switching mycobacterial respiration to cy-
tochrome bd that can be upregulated upon compound
FIG. 20. Possible contribution of cytochrome bd to the defense of mycobacteria against antibiotic-induced stress via
ROS detoxification. Protection of mycobacterial cells against CFZ, BDQ, and INH provided by the bd oxidase could be due
to its ability to scavenge and/or prevent generation of ROS induced by the antimicrobial compounds. ROS, reactive oxygen
species.
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treatment (113, 278). Accordingly, when cytochrome bd is
disrupted, the compounds become bactericidal (29, 113, 213).
Thus, cytochrome bd seems to protect mycobacteria
against cytochrome bcc inhibitors by providing an efficient
alternative respiratory route (Fig. 21).
VIII. Cytochrome bd As a Potential Therapeutic Target
During host colonization, pathogenic bacteria face hostile
environments, often characterized by harsh conditions, in-
cluding severe O2 limitation and abundance of harmful spe-
cies, such as ROS and RNS produced by the host immune
system, or high levels of H2S produced by coexisting bac-
teria. Under these conditions, expression of cytochrome bd is
potentially beneficial for pathogens, owing to the ability of
this enzyme to function even under O2-limiting conditions,
due to its high O2 affinity and resistance to cytotoxic species,
such as H2O2, ONOO
-, NO, and H2S. Therefore, it is not
surprising that, as summarized below, cytochrome bd pro-
motes virulence in several pathogenic bacteria.
In the case of Shigella sp., a well-known foodborne enteric
pathogen, a markedly attenuated virulence was observed in
mice models when CydAB expression was impaired by
mutation of the cydC gene in the same operon. On the con-
trary, overexpression of CydAB in response to impaired
synthesis of ubiquinone or riboflavin resulted in significantly
higher bacterial virulence (334).
The role of cytochrome bd in bacterial virulence was also
investigated in Group B Streptococcus, a common constituent
of the vaginal microflora whose transmission to newborns
during delivery can result in life-threatening sepsis. This path-
ogen, commonly assumed to have a strictly fermentative me-
tabolism, was shown to adopt a quinone- and haem-dependent
respiration-based metabolism requiring cytochrome bd (341).
Inactivation of cydA in this pathogen was reported to result in
reduced growth in human blood and, importantly, attenuated
virulence in a neonatal rat sepsis model (341).
Another interesting case is represented by S. Typhimurium,
a well-known foodborne pathogen responsible for a broad
disease spectrum, ranging from self-limiting gastroenteritis to
acute systemic infection in susceptible patients. As in E. coli,
this enteric pathogen encodes two bd-type oxidases: cyto-
chrome bd-I and cytochrome bd-II, respectively, encoded by
cydAB and cyxAB. Whereas cytochrome bd-II was found to be
essential for intestinal colonization following antibiotic
treatments depleting the gut of Clostridia species (275), cy-
tochrome bd-I appears indispensable for sustaining tissue
infection in mice models (85). Interestingly, the role of cy-
tochrome bd-I in S. Typhimurium virulence was related to the
ability of this oxidase to sustain bacterial energy metabolism
under O2-limiting conditions and to play a key role in the
defence against nitrosative stress together with the NO-
detoxifier flavohemoglobin (Hmp) (161).
The importance of cytochrome bd in affording NO-resistant
respiration during the infection process was also demonstrated
by Shepherd et al. (295) for uropathogenic E. coli (UPEC), a
major cause of urinary tract infections, which are the most
common nosocomial infections in developed countries. In this
study, the relative contribution of the NO-detoxifying systems
(Hmp, NorVW, NrfA), the iron/sulfur cluster repair protein
YtfE, and the NO-tolerant cytochrome bd-I to UPEC growth
and survival during infection was investigated. Cytochrome
bd-I was shown not only to confer the highest resistance
(together with Hmp) to an NO releaser but also to contribute
to resistance to neutrophil-mediated killing and enable sur-
vival within macrophages. In addition, unlike the other de-
fence systems (NorVW, Hmp, and YtfE), cytochrome bd-I
was found to enhance UPEC survival in a mouse model after
two days. On this basis, it was concluded that in UPEC, cyto-
chrome bd-I is the main contributor to NO tolerance and
host colonization under microaerobic conditions.
Cytochrome bd was also shown to play a role in the vir-
ulence of Listeria monocytogenes (77), another foodborne
pathogen responsible for a number of life-threatening in-
fections. This pathogen requires a special ability to adapt to
varying O2 levels. It encodes two respiratory terminal oxi-
dases, a cytochrome bd-type (CydAB) and a cytochrome
aa3-type MQH2 (QoxAB) oxidase. Both are used for res-
piration at different O2 tensions and, importantly, have a
role during infection, as mutation of either oxidase results in
attenuated infection in mice. However, only the cytochrome
bd-type oxidase is essential for aerobic respiration and
bacterial replication in HeLa cells.
Less clear is the role played by cytochrome bd during
the infection of Brucella spp., the pathogens responsible
for brucellosis, a disease characterized by protracted recur-
rent fever in humans and abortion in ruminants. As a strat-
egy to evade the host defence mechanisms, the Brucella
spp. undergoes replication inside host macrophages, facing
O2-limiting and hyperoxidative conditions. In an early study
on B. abortus, cydB mutants were found to display higher
sensitivity to killing in murine macrophages and attenuated
virulence in a mouse model, reverted by genes encoding
superoxide dismutase or catalase (107). In a later report on
Brucella suis, cytochrome bd was found to be the preferen-
tially used terminal oxidase inside macrophages and to con-
tribute to intracellular replication (208). However, in a
subsequent study by the same group, lack of cytochrome bd
was found to lead to bacterial hypervirulence (not attenua-
tion) in a mouse model (157).
The role of cytochrome bd in microbial virulence was
thoroughly investigated also in mycobacteria. M. tuberculosis
FIG. 21. Possible contribution of cytochrome bd to the
protection of mycobacteria against cytochrome bcc in-
hibitors. The bd oxidase may provide an alternate respira-
tory route for electrons transferring from MQ to O2 if
cytochrome bcc is inhibited by telacebec (Q203), TB47,
LPZ, PABs, and arylvinylpiperazine amide (AX-35). MQ,
menaquinone.
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can survive, but not proliferate, under O2-limiting conditions.
As reviewed in Cook et al. (73), this pathogen has a versatile
respiratory metabolism enabling bacterial survival at the sig-
nificantly varying O2 tensions encountered during host infec-
tion. The respiratory electron transfer chain is branched and
terminates with two terminal oxidases: a bd-type oxidase
(CydAB) and an aa3-type cytochrome c oxidase that form a
supercomplex with bc1 (denoted as bc1-aa3). As revealed by
investigating both M. tuberculosis (23) and the closely related
nonpathogenic M. smegmatis (176), in the absence of stress
factors, cytochrome bd is dispensable for growth in a rich
medium. However, it appears to have a role in mycobacterial
virulence, particularly at the transition between acute and
chronic infection, when cytochrome bd and a nitrate transporter
were shown to be transiently upregulated in a transcriptomic
study on a murine infection model (296).
Mutation of cydC resulted in a lower bacterial burden in
this transition phase, but not in the acute phase of infection, as
observed in the same animal model (296). Although this
observation was not reproduced in a later study (173), it is
conceivable that cytochrome bd has a role during infection,
when M. tuberculosis is expected to encounter several
stresses, including limiting O2 tensions, NO, and ROS/RNS
produced by the host immune system. In line with this view,
NO and hypoxic conditions were reported to enhance cydAB
expression inM. tuberculosis and other mycobacteria (22, 33,
79, 127, 176, 296), and knockout of cytochrome bdwas found
to impair mycobacterial growth at low O2 tensions (176, 296)
and in the presence of H2O2 (212). Conversely, compared
with the WT, a higher resistance to H2O2 was observed in an
M. tuberculosis mutant strain with enhanced expression of
cytochrome bd (305).
Altogether, the evidence reviewed above points to cy-
tochrome bd as a prospective target for the development of
next-generation antibiotics. However, a thorny path may
await us. The flexibility of the Q-loop poses a problem to
structure-driven design of quinone substrate-like inhibitors
(280). For bd-type oxidases structurally similar to the E.
coli bd-I, one could try to design hydrophobic compounds
that would block the oxygen channel functioning. One
more option is to develop quinol-like inhibitors that would
compete with ubiquinol-8 for the CydB binding site,
thereby preventing correct assembly of a CydAB core di-
mer (280).
IX. Possible Biotechnological Applications
Oxidases of the bd type have a broad potential application
for biotechnology. This may relate to (i) the monitoring of
parameters in biotechnological production processes, (ii) the
creation of microbial fuel cells, (iii) the selection of industrial
strains of microorganisms resistant to toxins and copper
deprivation, (iv) various issues of bioremediation and
wastewater treatment, and (v) the creation of conductive
systems based on immobilized biofilms on the electrode.
Some real and potential applications of cytochromes bd in
industrial and medical biotechnology are illustrated by the
following examples.
Forced aeration is one of the major energy consumption
factors of bioleaching processes. The ability of cytochrome
bd to be expressed under low oxygen conditions has been
used for the identification and validation of genetic markers
associated with oxygen availability in low-grade copper
bioleaching systems (78).
Strains of C. glutamicum are used in the biotechnology
industry for production of million tons of amino acids, mainly
L-glutamate and L-lysine (95). In C. glutamicum, the respi-
ratory chain, which includes cytochrome bd, was shown to be
a target for improving amino acid production (171). These
processes depend on aspects of respiration and how a cell
responds to altered gene expression, including those encod-
ing cytochrome bd (95, 184).
Extracellular electron transfer (EET), that is, electron
movements outside the envelope of microbial cells, is
highly relevant to the design of electrochemical systems,
construction of fuel cells and biosensors, and understanding
the physiology of the gut microbiota. Cytochrome bd ac-
tivity was shown to attenuate EET in the gram-positive
lactic acid bacterium Enterococcus faecalis through its ef-
fects on the redox status of the MQ pool. Wiring respiratory
electron transfer from a bacterium such as E. faecalis to an
electrode could be used as a sensor in screens for antimi-
crobial compounds acting by inhibition of cytochrome bd
(240).
Mining, jewelry, and metal-processing industries use
cyanide for extracting gold and other valuable metals,
generating large amounts of highly toxic wastewater. There
are microorganisms (e.g., Pseudomonas pseudoalcaligenes
CECT5344) that can grow under alkaline conditions using
cyanide, cyanate, or different nitriles as the sole nitrogen
source, and are able to remove cyanide from a jewelry
industry wastewater. These bacteria will enable the devel-
opment and optimization of improved strategies for bio-
degradation and bioremediation of industrial cyanide- and
metal-containing effluents. As cyanide generally inhibits
cellular aerobic respiration, bacteria possessing an alterna-
tive oxidase insensitive to cyanide, such as the quinol oxi-
dase encoded by the cioAB genes, which belongs to the
cytochrome bd family (60).
The study of bd-type oxidases also contributes to the de-
velopment of means to combat biofilms in food and medical
biotechnology. Cytochrome bd, a high-affinity quinol oxi-
dase required for aerobic respiration under hypoxic condi-
tions, is the most abundantly expressed respiratory complex
in the biofilm community. It was shown recently that the
cytochrome bd-expressing subpopulation is critical for bio-
film development (14).
X. Conclusions
Cytochrome bd is found only in bacteria but is widely
distributed among taxa and physiological types. However, its
current importance and high profile were slow to be recog-
nized: since its discovery by Keilin, Warburg and pioneers in
respiratory metabolism in the 1930s (when it was named
cytochrome a2), publications on this oxidase accrued very
slowly. Based on the Web of Science Core Collection, the
number of articles has grown rapidly: in 1990, there was one
article (searching for ‘‘cytochrome AND bd’’), but now that
number is *1500 per annum. The explosion of interest is a
result of the recognition that cytochrome bd represents a
novel class of oxidase and that its unique structure, catalytic
capabilities, tolerance of stress, and importance to pathogens
are worthy of detailed study.
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Despite impressive advances, significant challenges re-
main. From the point of view of fundamental understanding
of redox and antioxidant biology, the most pressing are a full
description of electron flux through the three haems and the
mechanisms of oxygen reduction. Since cytochrome bd is not
a proton pump, although contributing to creation of a proto-
nmotive force, accompanying proton movements are less
problematic. However, the novel features of cytochrome bd
pose additional challenges, particularly its ability to confer
upon bacterial resistance to oxidative stress, NO and a
number of important antimicrobial compounds. Its unique
structure and function make it a profitable area of study for
developing novel therapeutics, thereby contributing to over-
coming the global scourge of resistance to established, and
overused, antibiotics.
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Abbreviations Used
s¼ time constant, reciprocal of rate constant









CRP¼ cAMP receptor protein
Cryo-EM¼ single-particle cryoelectron microscopy
DNA¼ deoxyribonucleic acid
EET¼ extracellular electron transfer
F¼ cytochrome bd species with ferryl haem d





hCAP-18¼ human cationic antimicrobial protein
Hmp¼flavohemoglobin





koff¼ dissociation rate constant







NADH¼ nicotinamide adenine dinucleotide
(reduced form)
NO¼ nitric oxide






P¼ cytochrome bd species with peroxy complex
of haem d
PAB¼ phenoxyalkylbenzimidazole
PDB¼ Protein Data Bank





R¼ cytochrome bd species with ferrous
uncomplexed haem d
RMSD¼ root mean square deviation
RNA¼ ribonucleic acid
RNAP¼RNA polymerase
RNS¼ reactive nitrogen species
ROS¼ reactive oxygen species
TB47¼ pyrazolo[1,5-a]pyridine-3-carboxamide
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